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v 
Abstract 
 Campylobacter jejuni is the leading cause of food borne bacterial enteritis in the 
United States, as well as around the world, and is commonly contracted after consuming 
contaminated meat (especially poultry), unpasteurized milk, or contaminated drinking 
water.  Since the ability of this bacterial species to respond to changes in the extracellular 
environment is paramount to its ability to cause disease, the mechanisms responsible for 
adaptation provide a viable target for bacterial control.  The autoinducer-2 (AI-2) 
mediated quorum sensing system is widely conserved over both gram negative and gram 
positive bacteria and has been demonstrated to play a critical role in the environmental 
adaptation of other enteric pathogens such as E. coli and Salmonella sp.  Previous work 
has demonstrated that the C. jejuni genome encodes a functional luxS gene capable of 
producing AI-2 as a byproduct of its other role in s-adenosylmethionine (SAM) 
recycling, a normal metabolic pathway of bacteria.  Several studies have started to 
evaluate the role of luxS and AI-2 mediated quorum sensing in C. jejuni, however many 
gaps still exist in our knowledge of how this system may play a role in the molecular 
response to environmental stimuli including in-host conditions.  Work conducted as part 
of this thesis addresses three critical questions regarding luxS mediated quorum sensing 
of C. jejuni.  First, we provide additional insights into the mechanisms of AI-2 synthesis 
by identifying a key amino acid of the LuxS enzyme that is critical for production of AI-2 
in Campylobacter. Secondly, we demonstrate that luxS and/or AI-2 are critical to the 
competitive fitness and virulence of C. jejuni in two separate in vivo models of 
colonization and disease.  Finally we evaluate the transcriptional and phenotypic changes 
associated with mutagenesis of this quorum sensing system and identify additional targets 
vi 
for future research to understand the function of quorum sensing in Campylobacter 
pathobiology.  The collective results of these experiments complement each other and 
provide strong evidence for a critical role of the LuxS system of C. jejuni in 
environmental adaptation and pathogenesis.   
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Chapter 1: 
Introduction and Literature Review 
Bacteriology 
 Campylobacter jejuni is a gram-negative curve-shaped to spiral rod bacterium 
with one or two single unsheathed polar flagella.  The organism is a member of the 
Campylobacteriaceae family along with Arcobacter, Bacteroides ureolyticus and 
Sulfurospirillum, all of which are nonsaccharolytic organisms that prefer microaerophilic 
growth conditions (14). As nonsaccharolytic organisms, they lack a 6-
phosphofructokinase gene and thus lack the ability to catabolize hexose-sugars, instead 
relying on the uptake and utilization of amino acids (particularly serine and aspartate) or 
tricarboxylic acid intermediates as their primary source of energy.  Consequently, they 
have a substantial ability to uptake amino acid substrates from their environment while 
they encode relatively few carbohydrate transporters (26). Biochemically they are 
typically oxidase positive, can reduce fumurate to succinate and are frequently difficult to 
speciate by biochemical methods due to a relative biochemical inertness.  As a genus, 
they have a very low G+C content with averages of 29-47 mol% (14). 
 
Broad Host Range 
 C. jejuni is almost ubiquitous in its environmental distribution and is a common 
commensal inhabitant of the gastrointestinal tract of many mammals and birds.  Isolates 
obtained from various animal and environmental sources are genetically diverse, however 
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there is a strong clonal complex association that appears to be related to genetic similarity 
arising in particular biological and environmental niches (32). Studies have demonstrated 
that the intraspecies gene content similarity values for C. jejuni can go as low as 74%, a 
value that demonstrates an immense capacity for ecological versatility.  This diversity is 
demonstrated by the 2,250 strain types (STs) present in the pubMLST database that 
reside in 42 clonal complexes representing distinct genetic lineages.  Population ecology 
studies have further demonstrated that particular clonal complexes can be linked with 
specific ecological niches. For example, in one study of variant alleles, 18 of 22 ST-21 
complex isolates were correctly predicted to have arisen from their isolation source host 
based on a structure algorithm (32). Thus, C. jejuni is a highly adaptable organism with a 
broad host range that specializes in ecological adaptation and maintenance.  This ability 
to adapt provides a possible explanation for the difficulty experienced in controlling the 
disease associated with the organism.    
 
Pathogenesis and invasion of C. jejuni 
 Microscopic examination of intestinal and placental tissue derived from clinical 
cases or in vitro invasion assays clearly demonstrates that C. jejuni is capable of being 
internalized into the cells of eukaryotic host  (5, 29, 35, 45).  Unlike many other enteric 
pathogens, this process appears to be independent of the actin cytoskeleton and instead 
relies on a microtubule based mechanism (35). The molecular mechanisms used by C. 
jejuni to facilitate invasion are for the most part poorly understood.  One consistent 
phenotype that appears to be required for invasion is motility  (9, 19).  In fact, non-motile 
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isolates are almost completely unable to invade host cells (47). Additional studies have 
implicated the polysaccharide capsule and some specific protein products (e.g. CiaB) as 
being important in the process, however the results are often inconclusive and have been 
questioned by other research groups (47). Once internalized the organism is found in 
cellular structures termed C. jejuni containing vacuoles that remains a membrane bound 
compartment but mature independent of the normal endocytic pathway and do not result 
in formation of a lysosome (27, 40, 47, 48). In most intestinally derived cell-culture 
systems the organism appears to develop decreased viability following internalization and 
do not replicate (8, 28, 33).  In contrast, the presence of large numbers of bacterial cells 
in the trophoblast of guinea pig and sheep placentas following abortion would suggest the 
possibility that C. jejuni can replicate in some cells (5). Clearly, internalization of C. 
jejuni by host cells plays an important role in the pathogenesis of disease caused by this 
organism, however there are significant gaps in our knowledge of the specific 
mechanisms responsible for this process and the adaptation of the organism to growth in 
the intracellular environment. 
 
Significance of C. jejuni as a food borne pathogen 
C. jejuni is a leading cause of bacteria-associated food borne illnesses in the 
United States and other developed countries. It is also an agent included in the list of 
NIAID Category B Priority Pathogens. Consumption of unpasteurized milk (2, 34, 42), 
undercooked meat (34) and improperly treated surface water (42) are the most commonly 
identified sources of exposure, however contact with domestic/agricultural animals and 
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foreign travel can also be sources of isolated cases (30, 42). Published data collected from 
FoodNet between 1996-1999 suggest that there are approximately 21 culture confirmed 
cases/100,000 population annually and estimates the actual case burden at between 1.4 
and 2.3 million persons per year (42).  Additionally, estimates put the total cost of 
Campylobacter infections, sequella and lost productivity at between 0.6 and 8.0 billion 
dollars annually (6, 7).  In a subset of individuals the organism acts as an antecedent 
infection leading to Guillian-Barré syndrome, an acute autoimmune mediated 
neuromuscular paralytic disease.  Approximately 1 in every 2000 individuals infected 
with Campylobacter develops Guillian-Barré syndrome, representing the antecedent 
event in up to 40% of the diagnosed Guillian-Barré patients (1, 7, 38).  Traditionally, the 
mortality associated with campylobacteriosis was considered minimal. However, recent 
work suggests that after adjusting for comorbidity the mortality in Campylobacter 
patients was 1.86 times higher than that for the matched cohort group of people from the 
general population during the first year following diagnosis (21). As a food borne human 
pathogen of animal origin, C. jejuni is able to adapt to various niches and colonizes 
animal hosts at a high level.  
 
Quorum-sensing mediates cell-cell communication in bacterial species   
The first evidence of bacterial communication came from the study of density 
dependent bioluminescence of Vibrio fischeri (16, 17). The induction of bioluminescence 
was found to be mediated by the concentration-dependent action of small signaling 
compounds produced by the bacteria and termed autoinducers.  This work provided the 
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basis for the quorum-sensing model in gram-negative bacteria where an acyl-homoserine 
lactone (HSL) autoinducer (AI-1) accumulates in the extracellular environment and freely 
diffuses into the bacterial cytoplasm.  When intracellular autoinducer levels reach a 
critical threshold concentration it binds to a cellular transcriptional activator (luxR 
homologue) that is responsible for luciferase gene induction (3).  Subsequent work has 
demonstrated a similar system in over 30 species of gram-negative bacteria where it 
exerts control over a variety of cell density dependent processes. In contrast, gram-
positive species have been demonstrated to produce small peptide signaling molecules 
that are secreted through the action of an ABC transporter protein system (3).  The 
extracellular autoinducers are then recognized by a cognate two-component sensor kinase 
that initiates a phosphorelay signal transduction cascade.  Perhaps most intriguing is the 
identification of a third quorum-sensing mechanism that appears to be highly conserved 
over a variety of gram-negative and gram-positive organisms.  In these organisms the 
luxS gene is responsible for the synthesis of a novel autoinducer termed autoinducer-2 
(AI-2), which has mechanisms reminiscent of both the gram positive and gram negative 
systems.  According to genome sequences, C. jejuni does not possess acyl-HSL 
synthetases and the AI-1 sensing system, but possesses a luxS homolog (18, 36). 
 
LuxS is responsible for the production of AI-2 in bacterial species   
AI-2 production by the S-ribosylhomocysteinase, LuxS, was first described in 
Vibrio harveyi as a result of work on bioluminescence by this organism (4). It was 
discovered that as the bacterial population grew, the environmental concentrations of AI-
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2 increased and that the presence of a critical concentration of this signal was necessary 
for bioluminescence of the organism.  LuxS cleaves S-ribosylhomocysteine to form 
homocysteine and 4,5-dihydroxy-2,3-pentanedione (DPD) which is then spontaneously 
cyclized to form AI-2 (Figure 1) (13, 37, 50).  As this system has been evaluated in a 
number of species it has become clear that the spontaneous cyclization of DPD does not 
produce a single molecular compound but instead can produce multiple molecules with 
varying abilities to bind AI-2 receptors. This has led to the use of the term “AI-2” to 
collectively represent a variety of molecular variants that result from spontaneous 
changes to DPD and act as ligands of AI-2 receptors (46). Recent work even suggests that 
these molecules are able to interconvert allowing for the inclusion of mixed bacterial 
populations in the quorum recognized by a single species (51). The molecular form of 
AI-2 produced by C. jejuni is unknown at this time, however previous work by other 
groups and our study have demonstrated that it is active as a luxP ligand during in vitro 
bioluminescence assays with a Vibrio harveyi reporter strain (15, 24). 
Crystal structures of the LuxS homologues suggest that the protein forms a 
homodimer with a highly conserved active site (46).  Structural studies have 
demonstrated that the LuxS protein forms a secondary structure containing a four-
stranded antiparallel β sheet interacting with four α helices (22, 31, 41). The LuxS 
structural fold observed in all of these crystals is highly conserved and appears to be a 
new type of fold in the alpha-beta family (31).  At the interface of the homodimer two 
identical active sites are present with a tetrahedrally coordinated Fe2+. Homodimerization 
also leads to the formation of two deep pockets adjacent to the active sites. The function 
of the pockets is still unclear, but they were demonstrated to hold a covalently bound 
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homocysteine molecule in at least one study (41). The proposed enzymatic activity 
involves a series of proton transfer reactions, catalyzed by two Lewis acid/bases and the 
divalent metal ion (53).  Although the LuxS protein of Campylobacter jejuni has not been 
crystallized, the gene sequence shows a high degree of homology to other sequenced 
strains (74% aa identity to LuxS from Vibrio harveyi, 71% aa identity to LuxS from E. 
coli, and 73% aa identity to LuxS from Pasteurella multocida) and would be expected to 
have a similar structure (15). 
 
Bacterial sensing of environmental AI-2 is mediated by multiple mechanisms  
Variation has been demonstrated in the mechanism of cellular recognition of 
environmental autoinducers. The model system, Vibrio harveyi, uses a well described two 
component sensor kinase system (LuxP/Q) to initiate a phosphorelay signal transduction 
event that ultimately leads to dephosphorylation of the response regulator (LuxO) and 
changes in gene expression (4).  Salmonella and, more recently, E. coli have both been 
demonstrated to rely on a periplasmic binding protein (LsrB) that recognizes the AI-2 and 
leads to internalization via an ABC transporter (encoded by the lsrACDBFGE operon) 
where the AI-2 is phosphorylated and regulates gene expression via LsrR (44, 52).  
Recent evidence suggest that chemical interconversion of AI-2 may also allow the signal 
of one species to effect the response of another species (51). At present, no mechanisms 
of cellular recognition of AI-2 are currently known for Campylobacter.   
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LuxS plays an important role in a variety of molecular processes across the 
spectrum of bacterial species  
 Alterations in biofilm formation, growth rates, antimicrobial production, motility, 
toxin secretion and colonization have been observed with luxS mutants of different 
bacterial species (46).  For an excellent review of the currently described phenotypic 
changes in more than 15 species see the paper by Vendeville et. al. (46). The 
experimental design of many of these studies involves mutation of luxS and subsequent 
evaluation for phenotypic changes.  As LuxS is required for both homocysteine 
production and AI-2 synthesis, the phenotypic changes associated with the luxS mutants 
could be due to AI-2 mediated quorum sensing or the loss of metabolic function of LuxS.  
Currently, the lsr system responsible for the uptake and processing of AI-2 in Salmonella 
spp. and E. coli is the only genetic system for which a definitive role for AI-2 in the 
regulation of gene expression has been demonstrated outside of the Vibrio genus where 
quorum sensing was first described (46).  Most other studies demonstrate the phenotypic 
changes in the presence of reduced AI-2 levels but fail to demonstrate the direct link of 
the autoinducer presence with the phenotype. This issue of dissecting the significance of 
metabolic changes versus AI-2 synthase activity (and the subsequent presence of AI-2 in 
the environment) has been addressed by several authors and represents a significant 
challenge in this field of research (12, 46). A recent study in Listeria monocytogenes 
demonstrated that the increased biofilm thickness observed in luxS mutant strains may be 
associated with increased levels of s-ribosylhomocysteine in the media of the mutant 
strain presumably associated with the metabolic deficiency of the enzyme and not the 
lack of AI-2 (10). Despite the shortcomings of some experimental designs at 
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differentiating these roles many of the observed phenotypic changes associated with AI-2 
in other species involve essential molecular processes or virulence factors. As such, the 
findings remain scientifically significant and relevant regardless of the exact mechanisms 
for the phenotypic changes. 
 
LuxS has also been associated with the production of another autoinducer named 
AI-3   
 Work conducted by Kaper et. al. demonstrated that in vitro synthesized AI-2 was 
unable to induce the expression of the locus of enterocyte effacement (lee) in E. coli and 
did not complement the type III secretion system phenotype observed in EHEC luxS 
mutants (43).  Furthermore, they demonstrated that using column purification they could 
induce lee expression and restore the type III secretion system with a purified fraction 
different from the fraction exhibiting AI-2 activity by the Vibrio bioluminescence assay.  
They associated this activity with a new autoinducer named AI-3 and developed a 
LEE1::lacZ fusion for assaying cell free supernatents for the presence of this compound.  
Importantly, mutation of the luxS gene in E. coli leads to the loss of both AI-2 and AI-3 
activity (52). Testing of Campylobacter cell free supernatants for the presence of AI-3 
using the LEE1::lacZ fusion kindly provided by Dr. V. Sperandio have failed to 
demonstrate such activity in Campylobacter  (unpublished data from our laboratory). 
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Roles of luxS and AI-2 mediated quorum sensing in Campylobacter  
 The publication of the first full genome sequence of C. jejuni in 2000 (36) 
allowed for the in silico identification of a luxS ortholog (Cj1198) in 2002 (15).  Elvers 
and Park were able to demonstrate the presence of AI-2 activity in growth media of C. 
jejuni using the AI-2 bioluminesence assay reported by Bassler et. al (4) and were able to 
eliminate the AI-2 activity by insertional mutation of the luxS gene.  The authors were 
unable to demonstrate any differences in growth rate, resistance to oxidative stress or in 
vitro invasion assays, but did show a decrease in motility of the mutant compared to the 
parent strain.  Cloak et. al. subsequently confirmed the presence of a functional luxS gene 
and production of active AI-2 using the same bioluminescence assay (11).  Additionally, 
they were able to demonstrate measurable levels of AI-2 in milk and chicken broth 
inoculated with Campylobacter, suggesting that the nutrient requirements necessary for 
autoinducer-2 are present in common food sources.   
In an attempt to explain the decreased motility of luxS null mutants, Jeon et. al. 
evaluated transcription of the two major flagellin genes (flaA and flaB) using a primer 
extension assay (24).  Using this assay they observed a 57% reduction in the transcription 
of flaA in the luxS mutant background comparing to the wildtype strain.  They were 
unable to demonstrate a difference in FlaA protein levels using western blotting and did 
not see a difference in flagellar structure based on transmission electron microscopy.  
Additionally, they were able to demonstrate decreased agglutination ability of the mutant 
strain. This change is presumably mediated by altered expression of surface proteins or 
flagella since a previous study has demonstrated a complete loss of agglutination in 
flagellar ablated strains (19).  No significant changes were observed in the expression of 
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flaB using the primer extension assay.  The same group also evaluated the role of AI-2 in 
expression of the cytolethal distending toxin, a putative virulence factor for C. jejuni  
(25).  Using a primer extension assay they were able to demonstrate a 39% decrease in 
cdt gene transcription when luxS was mutated.  One biological function of CDT involves 
the arresting of the cell cycle in the G2/M phase (49), and they were able to demonstrate a 
statistically significant decrease in number of cells arrested in this phase in the luxS 
mutant (25). 
 In 2007, Reeser et. al. demonstrated that luxS and flagellar structure may be 
important for C. jejuni biofilm growth since isolates that were mutagenized in one of 
those genes had significantly decreased biofilm formation using a simply static biofilm 
assay (39). The overall significance of biofilms in the physiology and survival of C. 
jejuni is still not well understood, so the importance of these findings to bacterial survival 
or persistence in the environment is unclear presently.  There is one published paper that 
has evaluated the role of luxS utilizing a full genome microarray.  In this study they 
performed a cDNA microarray comparing the mRNA levels of wildtype versus luxS and 
then the same assay in the presence of hydrogen peroxide.  Their results demonstrated 
altered expression of several flagellar, SAM metabolism and ABC transporter genes in 
the luxS mutant, which would be consistent with the published phenotypes (20). 
Interestingly, they observed that the mutant strain was more sensitive to the toxic effects 
of hydrogen peroxide and cumene hydroperoxide.  This phenotype was confirmed by 
altered expression of both the ahpC (encoding alkyl hydroperoxide reductase) and tpx 
(encoding thiol peroxidase) genes (20). Collectively these findings would suggest that the 
luxS gene or AI-2 plays a role in the response of C. jejuni to oxidative stress.  During this 
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study they did not compare the differential transcriptional regulation of C. jejuni luxS 
mutants in the presence or absence of exogenous AI-2, so it is difficult to dissect how 
much of the observed change was associated with the metabolic role of luxS as opposed 
to its role in AI-2 synthesis.  More recently, Holmes et. al. reported a microarray 
experiment designed to further evaluate the issue of AI-2 sensing by C. jejuni.  In their 
experiment they added exogenous AI-2 to the culture media of luxS mutant strains and 
evaluated transcriptional changes in gene expression.  They were unable to find a 
significant number of genes that were differentially expressed in the presence of 
exogenous AI-2 and concluded that most of the transcriptional changes observed in mid-
exponential growth luxS mutants of C. jejuni were the result of metabolic disturbances 
induced by altering the SAM recycling pathway.  They concluded that AI-2 mediated 
quorum sensing is not an important mechanism in mid-exponential growth of C. jejuni 
cultured in MH media (23). Prior to the description of these two microarray experiments 
we performed a similar set of microarray experiments that are detailed in chapter 3 of this 
thesis.   
While the presence of the luxS gene and its expression of a biologically functional 
AI-2 is certain in C. jejuni, the roles it plays in global gene regulation and its impact on 
the adaptation of Campylobacter to various environments are far from defined.  At 
present, fundamental questions remain concerning the molecular mechanisms of this 
quorum sensing system and its role in the pathobiology of Campylobacter. Previously 
published studies have confined themselves to only two phenotypic changes (motility and 
cytolethal distending toxin) associated with mutation of LuxS, and have failed to fully 
define the molecular mechanisms responsible for the altered phenotypes. In addition the 
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role of LuxS in Campylobacter pathogenesis has not been determined. The research 
detailed in this thesis was intended to close these knowledge gaps.  
 
Significance of this research 
This thesis represents a significant and timely project that is aimed to start to close the 
knowledge gap regarding the role of quorum sensing and LuxS in the environmental 
adaptation of C. jejuni.  The obtained results have allowed us to have a better 
understanding of the complex interactions occurring among Campylobacter populations 
and between the pathogen and animal hosts. The generated information will potentially 
facilitate development of novel measures to control Campylobacter transmission and 
colonization in the intestinal tract. Alternative control strategies for Campylobacter 
infections are imperative in the face of rising antimicrobial resistance in clinical isolates. 
In addition, the findings also provide new insights into the mechanisms and roles of AI-2 
mediated quorum sensing in the general field of bacterial pathobiology. 
 
Organization of this thesis 
This thesis presents three studies to 1) address the key role of the G92 amino acid of 
LuxS in the synthesis of AI-2 and enzymatic function of LuxS, 2) provide the first 
comprehensive evaluation of LuxS in Campylobacter fitness and pathogenesis using in 
vivo animal models, and 3) evaluate the genome-wide transcriptional changes and altered 
phenotypes associated with mutagenesis of luxS or in the presence/absence of exogenous 
AI-2.  Each of the above topics is presented as a separate chapter complete with figures 
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and references.  Following the last chapter, an overall summary is provided that provides 
general conclusions and direction for future research.  
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Figure Legends 
Figure 1. 
 
SAM recycling pathway.  The recycling of SAM is demonstrated with the activity of the 
LuxS protein resulting in the formation of DPD which then spontaneously cyclizes to 
form a variety of compounds collectively referred to as autoinducer-2. 
 
  
Figure 1. 
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Chapter 2: 
Identification of a key amino acid of LuxS involved in AI-2 production 
in Campylobacter jejuni. 
Abstract 
Autoinducer-2 (AI-2) mediated quorum sensing has been associated with the expression 
of virulence factors in a number of pathogenic organisms and has been demonstrated to 
play a role in motility and cytolethal distending toxin (cdt) production in Campylobacter 
jejuni.  We have initiated the work to determine the molecular basis of AI-2 synthesis and 
the biological functions of quorum sensing in C. jejuni. In this work, two naturally 
occurring variants of C. jejuni 81116 were identified, one producing high-levels of AI-2 
while the other is defective in AI-2 synthesis. Sequence analysis revealed a G92D 
mutation in the luxS gene of the defective variant.  Complementation of the AI-2- variant 
with a plasmid encoded copy of the wild-type luxS gene or reversion of the G92D 
mutation by site-directed mutagenesis fully restored AI-2 production by the variant. 
These results indicate that the G92D mutation alone is responsible for the loss of AI-2 
activity in C. jejuni. Kinetic analyses showed that the G92D LuxS has a ~100-fold 
reduced catalytic activity relative to the wild-type enzyme. Results of this study identify a 
previously undescribed amino acid that is essential for AI-2 production by LuxS and 
provide a unique isogenic pair of naturally occurring variants for us to dissect the 
functions of AI-2 mediated quorum sensing in Campylobacter.  
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Introduction 
 The role of quorum sensing in the adaptation and colonization of bacterial 
pathogens has been of increasing interest over the last decade.  A growing body of 
evidence suggests that the direct sensing of threshold levels of various quorum sensing 
compounds is associated with changes in gene regulation resulting in altered phenotypic 
expression of virulence factors (18, 21, 28). Examples of such changes include regulation 
of adherence, motility, toxin production and expression of type three secretion systems in 
a variety of bacteria species (6, 7, 9, 13, 16, 17, 31). While the quorum sensing 
mechanisms of gram-positive bacteria are often associated with the production and 
sensing of polypeptide signals, the autoinducers of gram-negative bacteria are more 
commonly acyl-homoserine lactones (2, 15). A hybrid form of quorum-sensing mediated 
by autoinducer-2 has been described as a highly conserved inter-species mechanism of 
communication with genetic conservation over a large number of both gram-positive and 
gram-negative bacteria (2, 36). Production of AI-2 requires the activity of a conserved 
LuxS protein, an S-ribosylhomocysteinase that converts S-ribosylhomocysteine into 
homocysteine and 4,5-dihydroxy-2,3-pentanedione (DPD) (28). Under physiological 
conditions, DPD spontaneously cyclizes to form a mixture of several furanones which are 
collectively referred to as AI-2.   
LuxS is a Fe2+ metalloenzyme whose catalytic mechanism has been extensively 
studied and is well defined (28, 30, 40, 41).  Two universally conserved residues, Cys-84 
and Glu-57 (amino acid numbering in E. coli LuxS), have been shown to act as critical 
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general acids/bases during catalysis.  In addition, several other active-site residues 
including Ser-6, His-11 and Arg-39 are also important for full activity (28, 41).   
 Campylobacter jejuni is a leading cause of foodborne bacterial enteritis in the 
United States and many developed countries (23, 25, 32). Foodborne cases are most 
commonly associated with the consumption of contaminated poultry products, milk or 
drinking water (25). Although the majority of cases result in relatively mild self-resolving 
enteritis, severe infections require treatment with antimicrobial compounds (5). The 
fluoroquinolone and macrolide classes of antimicrobials represent the most commonly 
prescribed drugs used in severe human infections (12). An increasing prevalence of 
antimicrobial resistant Campylobacter isolates has resulted in a renewed effort to identify 
novel means of control for this bacterial pathogen (12, 20). Results in other bacterial 
species have suggested that the quorum sensing mechanisms may represent a viable 
target for bacterial control (1, 8, 18, 21, 29, 35), however there are significant knowledge 
gaps in our understanding of the quorum sensing mechanisms of C. jejuni.  
In order to determine the viability of utilizing quorum sensing mechanisms of 
Campylobacter as a therapeutic target we must first expand our understanding of both the 
molecular mechanisms responsible for autoinducer production and their role in virulence. 
Currently, evidence suggest that AI-2 mediated quorum sensing may play a role in 
motility, in vitro bacterial agglutination, and the production of cytolethal distending toxin 
by Campylobacter jejuni (9, 11, 16, 17).  This paper details the identification and 
description of a naturally occurring LuxS mutant strain of C. jejuni and provides new 
insights into the molecular mechanisms of LuxS production and function in this 
organism.   
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Materials and Methods 
Strains and Culture Media/Conditions 
The parent strain used in this study was Campylobacter jejuni 81116 (NCTC 
11828), an isolate obtained from a human enteritis outbreak in a boarding school located 
in the United Kingdom in 1983 (26). The 81116AI2- variant is the AI-2 deficient clone of 
this strain maintained and passaged in the author’s laboratory.  The 81116AI2+ strain is 
the AI-2 competent clone obtained from an independent laboratory.  Other strains utilized 
in this study are detailed in Table 1.  All strains are maintained in 20% glycerol stock at -
80 ºC.  C. jejuni strains were passaged on Mueller-Hinton agar (without blood) or broth 
in a microaerophilic environment generated by the use of compressed gas (5% O2, 10% 
CO2, 85% N2).  Routine cultures were incubated at 42 ºC.  C. jejuni strains with 
antimicrobial resistance markers were grown on kanamycin (30 µg/ml) or 
chloramphenicol (4 µg/ml) when appropriate.  All Escherichia coli strains used for 
genetic manipulation were grown in Luria-Bertani (LB) broth or agar and incubated in a 
normal atmosphere at 37 ºC.  When needed, kanamycin (40 µg/ml ), chloramphenicol (20 
µg/ml), or ampicillin  (30 µg/ml) was added to the culture media.  Vibrio harveyi strains 
were grown in autoinducer broth (AB Broth) as described previously (3).   
 
Insertional Mutation of the LuxS gene of C. jejuni  
An isogenic luxS mutant of C. jejuni NCTC 11168 was constructed by insertional 
mutagenesis. Primers luxSF4 and luxSR4 were used to amplify a 445 bp luxS fragment 
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with a unique HindIII site in the middle region of the fragment. The PCR fragment was 
cloned into the pGEM-T Easy vector (Promega), resulting in the construction of pLUXS. 
Primers kanF and kanR were used to amplify the kan gene encoding kanamycin 
resistance from KAN-2 Transposon using the Pfu Turbo DNA polymerase (Stratagene). 
After the HindIII digestion, the kan PCR product was ligated to the HindIII digested 
pLUXS to obtain plasmid construct pLUXSK, which was then transformed into E. coli 
JM109. pLUXSK, which served as a suicide vector in Campylobacter, was introduced 
into C. jejuni NCTC 11168 using an electroporator (Gene Pulser Xcell System; Bio-Rad 
Laboratories). Transformants were selected on MH agar containing kanamycin 50 µg/ml. 
PCR analysis of the luxS mutant confirmed that the kan gene was inserted into the luxS 
gene in the same orientation as the luxS gene.  Natural transformation was used to move 
this gene insertion into additional C. jejuni strains as previously described (38). 
 
Vibrio harveyi autoinducer-2 bioassay   
Autoinducer-2 (AI-2) levels of cell-free spent culture media were measured using 
the Vibrio harveyi bioluminescence assay as previously described (37). Briefly, the cell-
free spent media was prepared by centrifugation of the sample at 10,000 x g for 5 minutes 
followed by filter sterilization through a 0.25 µm syringe filter.  Cell-free supernatant was 
immediately frozen at -80 ºC until being subjected to AI-2 measurement.  A 10 µL 
aliquot of each sample was used in the bioluminescence assay and the relative light units 
(RLU) of bioluminescence were measured using a Turner Biosystems Reporter 
Luminometer.  Cell free supernatant of Vibrio harveyi strain BB152 was used as a 
positive control and LB and MH broth media were both used as negative controls.  All 
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measurements were reported at the 3 hour incubation period when the difference between 
negative controls and positive controls routinely reached maximal levels. Results 
reported are the average of three independent assays. 
 
Complementation of LuxS deficient variant in trans   
Complementation of the AI-2 phenotype of the 81116AI2- variant was performed 
using a plasmid-carried luxS gene.   Briefly, the luxS open reading frame and 500 bp of 
the upstream region of non-coding sequence of 81116AI2+ were cloned into the pRY111 
vector (39). The vector was conjugated into 81116AI2- as described below and selected 
using MH media containing chloramphenicol (4 µg/mL).   
 
Site-directed mutagenesis   
Site-directed mutagenesis of the single nucleotide substitution found in C. jejuni 
strain 81116AI2- was performed in order to revert the substituted aspartic acid residue to 
the wild-type glycine found in the AI-2 competent 81116AI2+ strain.  Site-directed 
mutagenesis was performed using the Transformer Site-Directed Mutagenesis Kit 
(Clontech) according to the manufacturer’s recommendations.  Briefly, the full luxS ORF 
and approximately 500 bp of the upstream non-coding promoter region of strain 
81116AI2- was amplified using the luxSF7 (including a PstI site) and luxSR9 (including 
a XbaI site) primers.  The PCR products and the puc19 plasmid were each individually 
subjected to restriction enzyme digestion with PstI and XbaI.  Following digestion the 
samples were purified using a Qiagen PCR Clean-Up column and ligated using T4 ligase 
(Promega).  The plasmid was transformed into chemically competent DH5α cells 
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(Invitrogen) and selected using LB media containing 100 µg/ml ampicillin, X-Gal and 
IPTG. A single clone was selected and DNA sequencing confirmed the plasmid 
contained the appropriate insert.  Site-directed mutagenesis was performed using the 5’-
phosphorylated control selection primer provided in the kit and a 5’-phosphorylated 
mutagenesis primer designed in this study and called luxS256G.  The mutagenesis primer 
was designed to replace the adenine at nucleotide 256 of the C. jejuni luxS ORF with a 
guanine.  Selection of desired mutants was performed as described by the manufacturer 
using NdeI restriction enzyme digestion.  DNA sequencing was utilized to verify the 
isolation of puc256G, the puc19 plasmid containing the 81116AI2- luxS ORF with the 
A256G nucleotide mutation.  PCR amplification of the mutated luxS ORF and promoter 
region in the puc256G plasmid was performed using the luxSF7 and luxSR9 primers used 
above, digested with PstI and XbaI and ligated into a similarly digested pRY111 C. jejuni 
shuttle vector to yield the pRY256G plasmid.  To transfer the pRY256G shuttle vector 
into the C. jejuni 81116AI2- strain, conjugation was performed as previously described 
(24). 
 
Production of histidine-tagged recombinant LuxS protein   
Six-histidine-tagged recombinant proteins were produced in E. coli JM109.  The 
luxS ORF of both 81116AI2- and 81116AI2+ were cloned in frame into the multicloning 
site of the pQE30 expression vector (Qiagen).  The ORF was amplified by PCR using 
primers Cj1198F1 (including a BamHI site) and Cj1198R3 (including a PstI site), 
digested with BamHI and PstI, and ligated into a BamHI/PstI digested pQE30 plasmid.  
The authenticity of the plasmid was confirmed by sequencing the entire luxS gene. 
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Recombinant proteins were produced following the manufacturer’s recommendations for 
the pQE30 expression system. The eluted fraction was diluted to a total volume of 2.5 
mL with 10 mM phosphate buffer, desalted using a PD-10 desalting column (Amersham) 
and concentrated using a Millipore centrifugal concentration column with a 10,000 MW 
size exclusion (Millipore).  The concentration of the recombinant protein was determined 
using a standard BCA protein assay kit (Pierce).  The protein was diluted to 1 mg/mL and 
flash frozen at -80 °C in small aliquots.  Cobalt-substituted LuxS was prepared as 
previously described. (40)  Briefly, cells were grown in minimal media containing Co2+.  
At the time of induction, cobalt chloride was added to a final concentration of 10 µM, 
along with IPTG.  The cells were collected by centrifugation and resuspended in 4 ml of 
a lysis buffer (20 mM Tris, pH 8.0, 0.5M NaCl, 5 mM imidazole, 1% Triton X-100, 0.5% 
protamine sulfate and 70 µg/mL chicken egg lysozyme).  The sample was incubated at 4 
°C for 20 min and centrifuged.  The supernatant was mixed with 1.5 mL of Talon Cobalt 
Purification resin (Clontech) and the mixture was transferred into a 5-mL column 
(Qiagen).  The column was washed with 2 column volumes of washing buffer (20 mM 
Tris (pH 8.0), 0.5 M NaCl, and 5 mM imidazole) and the bound protein was eluted with 5 
mL of elution buffer (20 mM Tris (pH 8.0), 0.5 M NaCl, and 60 mM imidazole).  The 
eluted fraction was concentrated using a Centricon 10 (10,000 MW cutoff) to about half 
the volume and the protein was quantitated using a BCA Protein Assay Kit (Pierce).  
Glycerol was added to a final concentration of 20% and the proteins were flash frozen at -
80 °C.   
 
Circular dichroism of recombinant proteins  
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Circular dichroism analysis of the recombinant LuxS proteins from 81116AI2- 
and 81116AI2+ were performed to compare the secondary structure of the proteins.  The 
proteins were tested in a 10 mM phosphate buffer using a Jasco J-710 
Spectropolarimeter.  Measurements were recorded at a 0.2 nm resolution from 190 nm to 
260 nm with a sensitivity of 20 mdeg.  The assay was performed at room temperature.   
 
In vitro synthesis of S-ribosylhomocysteine   
S-ribosylhomocysteine was synthesized as previously described with slight 
modification. (34) A 10 mg/mL solution of S-adenosylhomocysteine (Sigma) was 
dissolved in 0.1 M HCl, boiled for 90 minutes and neutralized with an equal volume of 
0.1 M NaOH (10). ESI positive and negative mode mass spectroscopy was used to verify 
the disappearance of the SAH peak at 385 m/z and the presence of the expected 266 m/z 
SRH peak.  This method has previously been demonstrated to provide a relatively pure 
SRH product (34). Furthermore, incubation of the synthesized product with recombinant 
LuxS wildtype enzyme clearly demonstrated AI-2 synthesis while incubation of the 
recombinant enzyme with the SAH failed to produce measureable AI-2 or homocysteine.  
 
In vitro AI-2 synthesis reaction  
The ability of the recombinant LuxS proteins to synthesize biologically active AI-
2 was assessed essentially as previously described (34). Briefly, 100 µL of recombinant 
protein (1 mg/mL) was added to 300 µL of synthesized SRH (approximately 2.5 mg/ml) 
and the mixture was incubated at 37 oC for 1 hour.  Following the incubation the sample 
was applied to a Ultramax 5,000 MW cut-off centrifuge filter to remove the protein.  To 
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assess for AI-2 activity 10 µL of the filtrate was used in the Vibrio harveyi AI-2 bioassay 
as described above.  When the sample was to be used for quantification of homocysteine 
formation the incubation was modified slightly.  For these experiments 50 µL of 
recombinant enzyme (1 mg/mL) was added to 250 µL of SRH (~2.5 mg/mL) and the 
incubation time was shortened to 15 minutes due to the instability of the homocysteine at 
37 °C (34). 
 
Measurement of homocysteine formation by recombinant LuxS proteins   
In order to measure the homocysteine formation by the recombinant LuxS 
proteins a standard Ellman reaction was utilized to measure the formation of free thiol 
groups as previously described (34).  Briefly, an equal volume of the DTNB (Sigma) 
working stock (5 mM) was added to the filtrate obtained following the synthesis reaction.  
The absorbance at 412 nm was used to quantitate the homocysteine formed by the 
reaction. 
 
LuxS Activity Assay  
LuxS reactions were performed in a buffer containing 50 mM HEPES (pH 7.5), 
150 mM NaCl, 150 mM 5,5'-dithio-bis-(2-nitrobenzoic acid) (DTNB) and various 
concentrations of SRH (0-80 µM). The reactions were initiated by the addition of LuxS 
(final concentration 1.3 µM for wild-type and 8.4 µM for G92D mutant) and monitored 
continuously at 412 nm (ε = 14150 M-1 cm-1) in a Perkin-Elmer λ25 UV-VIS 
spectrophotometer at room temperature (23 °C). The initial rates recorded from the early 
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regions of the progress curves were fitted against the Michaelis-Menten equation V = kcat 
[E]0 [S]/(KM + [S]) using KaleidaGraph 3.5 to determine the kinetic constants. 
 
Quantitation of AI-2 in Culture Fluids  
Cell free supernatants of both 81116AI2- and 81116AI2+ cells were collected at 
specific time points during a 24 hour growth period. The cell density was determined by 
measuring the OD600. The cultures were centrifuged and filtered through a 0.25 µM 
Acrodisc filter to remove bacterial cells. The resulting supernatant (30−60 µL) was added 
to 1.0 µM LuxP137Dap in 50 mM Hepes (pH 7.0) and 150 mM NaCl, and the 
fluorescence spectra were recorded before and after incubation with 1.6 mM borate for 5 
min at room temperature (total volume 1 ml) (42). The AI-2 concentration was calculated 
from the fluorescence increase at 494 nm using known concentrations of DPD as 
calibration standards.  
 
Results 
Identification of a naturally occurring AI-2 deficient variant of C. jejuni. 
Several C. jejuni isolates commonly used for laboratory research were screened 
for their ability to synthesize AI-2. Surprisingly, the 81116 strain maintained in our 
laboratory (named 81116AI2- in this study) was found to be deficient in AI-2 synthesis 
when assessed by the V. harvyei AI-2 bioassay and compared to the bioluminescence 
obtained with other C. jejuni isolates and the negative controls. Unlike the positive 
control strains, 81116AI2- did not produce AI-2 during any stage of the growth phase 
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(Figure 1A).  Since the V. harveyi bioassay is not quantitative, we next determined the 
concentration of AI-2 in the culture fluids of 81116AI2+ and 81116AI2- cells using a 
LuxP-based fluorescent sensor recently developed by Zhu and Pei (42). For this 
experiment, 81116AI2+ and 81116AI2- were grown in MH media under identical 
conditions.  A sample of the culture media was collected at specified time points and the 
cell free supernatant was collected and mixed with the LuxP137Dap sensor protein (in 
the presence of 1.6 mM borate), and the fluorescence yield at 494 nm was measured.  
Comparison with AI-2 standards confirmed that the 81116AI2+ cells produced 
significant levels of AI-2 starting at ~9 h and the AI-2 level peaked at 42 µM at ~22 h 
(Figure 2). In contrast, the 81116AI2- cells produced no detectable amounts of AI-2 
(detection limit ~1 µM) at any stage. Complementation of the strain with a plasmid 
encoded copy of the LuxS ORF from an AI-2 producing strain of C. jejuni (NCTC 
11168) resulted in the production of AI-2 at levels comparable to positive control strains 
(Figure 1A). Since strain 81116 was known to be positive in previous studies by other 
laboratories (16), we obtained another culture (named 81116AI2+ in this study) of strain 
81116 from an independent laboratory (Michael Konkel, Washington State University) to 
verify the AI-2 deficient phenotype observed in strain 81116AI2-. It was found that the 
AI-2 level of 81116AI2+ as measured by bioluminescence assay was essentially identical 
to those produced by NCTC11168 and the VhBB152 positive control strain (Figure 1B). 
These findings suggest that 81116AI2- is an AI-2 deficient variant of strain 81116 and 
may harbor a genetic change that is responsible for the loss of AI-2 production. 
 
A single point mutation in LuxS is responsible for the loss of AI-2.  
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To determine the genetic basis for the phenotypic difference between 81116AI2- 
and 81116AI2+, we compared the sequences of the luxS gene in the two variants.  No 
difference was observed in the promoter region of the luxS gene, however, a single 
adenosine to guanosine mutation was observed at position 256 of the luxS gene in 
81116AI2-. This mutation results in the substitution of an aspartic acid for glycine-92 in 
the LuxS protein. Sequence alignment of 14 LuxS proteins from a wide range of bacterial 
species revealed that the glycine residue is conserved across all species (Figure 3).  To 
determine whether the G92D mutation is responsible for the loss of AI-2 production, we 
reverted the Asp-92 back to a glycine by site-directed mutagenesis.  Introduction of a 
plasmid copy of the revertant luxS gene into the 81116AI2- strain [AI2-(p256G)] restored 
its ability to produce AI-2 to the same level as the 81116AI2+ strain (Figure 1B). Thus, 
the deficiency in AI-2 production is caused by the G92D mutation.  
 
The G92D mutant LuxS protein is catalytically deficient.  
To determine whether the G92D mutant LuxS is catalytically deficient, we 
overexpressed both the wild-type and mutant LuxS proteins in E. coli with an N-terminal 
six-histidine tag and purified the recombinant proteins to near homogeneity by metal 
affinity chromatography (Figure 4A).  The circular dichroism spectra of the two proteins 
are identical, suggesting that the mutation does not significantly alter the secondary 
structure of the protein (Figure 6). Kinetic analysis showed that the wild-type LuxS 
enzyme from 81116AI2+ had a kcat value of 0.009 s-1, a KM value of 28 µM, and a kcat/KM 
of 332 M-1 s-1.  In contrast, the activity of the 81116AI2- (G92D) LuxS enzyme was too 
low to allow for accurate measurement of its kcat and KM values. Its kcat/KM value was 
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estimated to be ~3.5 M-1 s-1, which is a about 100-fold lower than that of the wild-type 
enzyme. Therefore, while the G92D mutant retains residual catalytic activity in vitro, this 
100-fold reduction in activity results in a phenotypic loss of AI-2 production in vivo. 
    
Evaluation of SRH levels in the cell free supernatant of cultures 
 Given that the LuxS protein of 81116AI2- is significantly reduced in its ability to 
convert SRH to homocysteine and DPD, we were interested in testing the SRH levels in 
the cell free media of the various bacterial cultures.  Previous work in other species has 
demonstrated elevated SRH concentrations in the culture supernatant of luxS mutant 
strains (14).  To test this we utilized the in vitro AI-2 synthesis reaction described above 
with the wildtype LuxS enzyme and the cell-free supernatant as the source of substrate.  
In order to prevent any cross contamination of the reaction with endogenously produced 
AI-2 the supernatant was boiled for 5 minutes prior to the reaction then allowed to cool.  
The data presented in figure 7 demonstrates that strains deficient in their ability to 
produce AI-2 (81116AI2- and LuxS-) yield higher RLU following in vitro synthesis 
when compared with AI-2 competent strains [81116AI2+ and AI2-(pD256G)].  Elevated 
RLU units following the reaction are consistent with the presence of an increased SRH 
concentration in the supernatant that is reacted to produce AI-2 in the presence of the 
functional recombinant LuxS enzyme.   
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Discussion 
C. jejuni 81116 is a commonly used laboratory strain that was originally isolated 
from an outbreak of enteritis in a UK boarding school in 1983 (26). Since that time the 
strain has been widely disseminated and maintained in laboratories around the world.  
Despite the fact that this strain of C. jejuni is laboratory adapted and has been subjected 
to repeated laboratory passage, evidence suggest that the isolate has maintained an 
amazing level of genetic stability over the last 20 years and that the AFLP pattern 
determined in 2001 was identical to the co-isolates that had not been passaged since 1983 
(22).  Despite this considerable genome stability, the data presented herein clearly 
demonstrates the presence of a single nucleotide substitution in the open reading frame of 
the luxS gene of 81116AI2- that results in a single amino acid substitution and the loss of 
AI-2 phenotype.  Identification of such a mutation is not precluded by the genetic 
stability described above since the sensitivity of the AFLP technique for the detection of 
specific single amino acid changes is extremely low for the portions of the genome not 
included in the restriction enzyme recognition sites.  
 Interestingly, two previous studies regarding AI-2 competence of C. jejuni have 
utilized isolates of 81116 and have demonstrated it to be AI-2 positive (11, 16). To 
confirm our results we were able to obtain genomic DNA of the 81116 isolate used by 
one of those laboratories as well as a second 81116 isolate (81116AI2+) originating from 
a third laboratory.  Our results indicated that 81116AI2- is a variant of strain 81116 and 
harbors a single nucleotide substitution in luxS.  This mutation results in the substitution 
of an invariant glycine residue for a much larger charged aspartate residue in LuxS.  
Based on crystallographic structures of several LuxS enzymes this residue is located at 
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the amino end of ß-strand 4 (33).  In this position it is located within a fraction of an 
angstrom from both the Cis-84 residue located 2 residues upstream and the Arg-39 
residue located on the adjacent ß2-strand.  Both of these amino acids play important roles 
in the kinetics of the enzymatic reaction and the stabilization of the enzymatic 
intermediates (28, 41).  We speculate that the substitution with a larger charged amino 
acid induces steric hindrance and electrostatic repulsion, which induces conformational 
changes that result in decreased enzymatic kinetics.  Specifically, we speculate that the 
presence of the larger aspartate residue results in either the ß4 strand being displaced 
away from the active site and pulling the Cis-84 residue out of its typical 3 dimensional 
position or the displacement of the ß2 strand towards the active site, resulting in the Arg-
39 residue displacement.  In either case the relative locations of these two residues would 
be disrupted, negatively impacting enzymatic function. Given the lack of significant 
change in circular dichroism spectra and the retention of some enzymatic activity, this 
conformation change is assumed to be minor and may only result in slight repositioning 
of some key active site residues. 
 To our knowledge this isolate represents the first description of a naturally 
occurring LuxS mutant phenotype of any bacterial species.  Previous studies have utilized 
site directed mutagenesis to explore the amino acids involved in the active site and have 
demonstrated significant reductions in the enzyme activity associated with mutagenesis 
of these active site residues (28, 41).  Data herein demonstrated that the single amino acid 
substitution described in this isolate results in significant reductions in enzymatic activity 
and ultimately the loss of AI-2 phenotype.  The circular dichroism spectra of the wildtype 
and mutant LuxS proteins were nearly identical (figure 6), suggesting that the secondary 
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structures of the proteins are largely conserved. While the ability of circular dichroism to 
accurately predict secondary structure in silico is limited, its ability to compare two 
proteins with similar secondary structures is much more robust (19).   
 Results of both the V. harveyi bioluminescence and FRET method demonstrate 
the phenotypic loss of AI-2 in the 81116AI2- variant when compared to 81116AI2+ and 
other C. jejuni strains (figures 1B and 2).  In contrast, the in vitro s-
ribosylhomocysteinase enzymatic kinetics demonstrated that relatively low levels of 
enzymatic activity were still retained in the mutant LuxS.  This retained but limited 
enzymatic ability explains the detection of AI-2 production following in vitro incubation 
of concentrated recombinant mutant enzyme with excess of SRH (figures 3B and 4).  
Based on the enzyme kinetics of the wildtype protein kcat/Km of 332/M/s and that of the 
mutant protein at roughly 3.5/M/s, we can estimate that the mutant protein has a roughly 
100-fold decrease in enzymatic activity.  As a result, we believe that the physiological 
concentrations of AI-2 produced during the in vitro growth of 81116AI2-, using the 
media described, fall below the limits of detection of our AI-2 assays (LOD for FRET 
~1uM) resulting in a phenotypic loss of AI-2 activity while maintaining a minimally-
functional LuxS enzyme.  Such levels would also fall well below the 40 uM 
concentrations observed in the wildtype strain during growth in the same media, however 
data regarding the concentration of AI-2 necessary to result in signaling of C. jejuni is 
currently unavailable and thus interpretation of the biological meaning of these levels is 
hampered. 
The use of the FRET AI-2 assay in this manuscript provides, to our knowledge, 
the first truly quantifiable data concerning the physiological concentrations of AI-2 
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produced by C. jejuni grown in in vitro environments.  While the ability of the organism 
to truly “sense” the compound is still unproven, this quantification data does provide 
much needed information concerning what range of potential concentrations of 
chemically synthesized AI-2 should be used to mimic natural production potentials.  
Based on our results we believe that concentrations between 0 and 40 µM are 
physiologically possible in logarithmic growth in MH media routinely used for C. jejuni 
growth.   
When comparing the results of the in vitro recombinant proteins enzymatic 
reactions we observe that while no homocysteine can be detected following incubation of 
SRH with the rLuxS- enzyme we do see measurable synthesis of AI-2 (figure 5).  This 
provides additional evidence of retention of low-level enzymatic activity of the 
81116AI2- strain but also provides clues into the biological sensitivity of two of the 
assays utilized in detection of luxS enzymatic activity, homocysteine formation using the 
Ellman reaction and AI-2 activity using the Vibrio harveyi assay.  Given that 
homocysteine will be produced in the in vitro reaction in a stoichiometrically identical 
concentration to DPD, that then becomes AI-2, the ability to detect low levels of AI-2 in 
the absence of homocysteine suggests that the lower limit of detection of the Ellman 
reaction, as performed in this manuscript, is greater then that of the Vibrio 
bioluminescence assay.   
As has been described for other organisms, the absence of a fully functional LuxS 
gene in C. jejuni does result in increased extracellular concentrations of SRH (Figure 7).  
The presence of increased SRH concentrations in the naturally occurring mutant strain 
suggests that despite measurable residual enzymatic activity of the mutant enzyme, the 
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metabolic ability of the organism to recycle SRH into the SAM recycling pathway is 
hindered.  Thus, in addition to the phenotypic loss of AI-2 activity this strain has a 
phenotypic change in SAM recycling which precludes the ability to attribute any of the 
phenotypic characteristics observed directly to the loss of quorum sensing. 
In conclusion, we have fully described the molecular basis for the loss of AI-2 
phenotype associated with a naturally occur LuxS mutant of C. jejuni.  Given that the 
amino acid responsible for this loss of function is highly conserved over a broad range of 
bacterial species, we speculate that homologous mutations in other bacterial species 
would also result in a loss of AI-2 phenotype.  Additionally, the fact that this amino acid 
mutation allows for the maintenance of relatively normal secondary structure while 
diminishing enzymatic activity to levels similar to that observed with luxS deletion 
mutants suggests that this amino acid is critical for normal enzyme function.  Use of this 
isolate may be helpful in further defining the roles of AI-2 in quorum sensing in a wide 
variety of bacterial species since it does provide a potential enzymatic intermediate 
between fully functional and enzymatically incompetent.    
 
References 
1. Alfaro, J., T. Zhang, D. Wynn, E. Karschner, and Z. Zhou. 2004. Synthesis of 
LuxS Inhibitors Targeting Bacterial Cell-Cell Communication. Organic Letters 
6:3043-3046. 
2. Bassler, B. L. 1999. How bacteria talk to each other: regulation of gene 
expression by quorum sensing. Current Opinion in Microbiology 2:582. 
3. Bassler, B. L., M. Wright, R. E. Showalter, and M. R. Silverman. 1993. 
Intercellular signaling in Vibrio harveyi: sequence and function of genes 
regulating expression of luminescence. Molecular Microbiology 9:773-786. 
4. Bassler, B. L., M. Wright, and M. R. Silverman. 1994. Multiple signalling 
systems controlling expression of luminescence in Vibrio harveyi: sequence and 
function of genes encoding a second sensory pathway. Mol Microbiol 13:273-86. 
39 
5. Blaser, M., and J. Engberg. 2008. Clinical aspects of Campylobacter jejuni and 
Campylobacter coli Infections., p. 99-122. In I. Nachamkin, C. Szymanski, and 
M. J. Blaser (ed.), Campylobacter. ASM Press, Washinton DC. 
6. Carter, G. P., D. Purdy, P. Williams, and N. P. Minton. 2005. Quorum sensing 
in Clostridium difficile: analysis of a luxS-type signalling system. J Med 
Microbiol 54:119-127. 
7. Challan Belval, S., L. Gal, S. Margiewes, D. Garmyn, P. Piveteau, and J. 
Guzzo. 2006. Assessment of the Roles of LuxS, S-Ribosyl Homocysteine, and 
Autoinducer 2 in Cell Attachment during Biofilm Formation by Listeria 
monocytogenes EGD-e. Appl. Environ. Microbiol. 72:2644-2650. 
8. Clatworthy, A. E., E. Pierson, and D. T. Hung. 2007. Targeting virulence: a 
new paradigm for antimicrobial therapy. Nat Chem Biol 3:541-8. 
9. Cloak, O. M., B. T. Solow, C. E. Briggs, C. Y. Chen, and P. M. Fratamico. 
2002. Quorum sensing and production of autoinducer-2 in Campylobacter spp., 
Escherichia coli O157:H7, and Salmonella enterica serovar Typhimurium in 
foods. Appl Environ Microbiol 68:4666-71. 
10. Dawson, R. M. C., D. C. Elliott, W. H. Elliott, and K. M. Jones. 1989. Data for 
Biochemical Research. Oxford University Press, New York. 
11. Elvers, K. T., and S. F. Park. 2002. Quorum sensing in Campylobacter jejuni: 
detection of a luxS encoded signalling molecule. Microbiology 148:1475-81. 
12. Engberg, J., F. M. Aarestrup, D. E. Taylor, P. Gerner-Smidt, and I. 
Nachamkin. 2001. Quinolone and macrolide resistance in Campylobacter jejuni 
and C. coli: resistance mechanisms and trends in human isolates. Emerg Infect 
Dis 7:24-34. 
13. Gonzalez Barrios, A. F., R. Zuo, Y. Hashimoto, L. Yang, W. E. Bentley, and 
T. K. Wood. 2006. Autoinducer 2 Controls Biofilm Formation in Escherichia 
coli through a Novel Motility Quorum-Sensing Regulator (MqsR, B3022). J. 
Bacteriol. 188:305-316. 
14. Heurlier, K., A. Vendeville, N. Halliday, A. Green, K. Winzer, C. M. Tang, 
and K. R. Hardie. 2009. Growth deficiencies of Neisseria meningitidis pfs and 
luxS mutants are not due to inactivation of quorum sensing. J Bacteriol 191:1293-
302. 
15. Jayaraman, A., and T. K. Wood. 2008. Bacterial quorum sensing: signals, 
circuits, and implications for biofilms and disease. Annu Rev Biomed Eng 
10:145-67. 
16. Jeon, B., K. Itoh, N. Misawa, and S. Ryu. 2003. Effects of quorum sensing on 
flaA transcription and autoagglutination in Campylobacter jejuni. Microbiol 
Immunol 47:833-9. 
17. Jeon, B., K. Itoh, and S. Ryu. 2005. Promoter analysis of Cytolethal Distending 
Toxin Genes (cdtA, B, and C) and Effect of a luxS Mutation on CDT production 
in Campylobacter jejuni. Microbiol Immunol 49:599-603. 
18. Kaufmann, G. F., J. Park, and K. D. Janda. 2008. Bacterial quorum sensing: a 
new target for anti-infective immunotherapy. Expert Opin Biol Ther 8:719-24. 
19. Kelly, S. M., T. J. Jess, and N. C. Price. 2005. How to study proteins by circular 
dichroism. Biochim Biophys Acta 1751:119-39. 
40 
20. Luangtongkum, T., B. Jeon, J. Han, P. Plummer, C. M. Logue, and Q. 
Zhang. 2009. Antibiotic resistance in Campylobacter: emergence, transmission 
and persistence. Future Microbiol 4:189-200. 
21. Lynch, S. V., and J. P. Wiener-Kronish. 2008. Novel strategies to combat 
bacterial virulence. Curr Opin Crit Care 14:593-9. 
22. Manning, G., B. Duim, T. Wassenaar, J. A. Wagenaar, A. Ridley, and D. G. 
Newell. 2001. Evidence for a Genetically Stable Strain of Campylobacter jejuni. 
Appl. Environ. Microbiol. 67:1185-1189. 
23. Mead, P. S., L. Slutsker, V. Dietz, L. F. McCaig, J. S. Bresee, C. Shapiro, P. 
M. Griffin, and R. V. Tauxe. 1999. Food-related illness and death in the United 
States. Emerg Infect Dis 5:607-25. 
24. Miller, W. G., A. H. Bates, S. T. Horn, M. T. Brandl, M. R. Wachtel, and R. 
E. Mandrell. 2000. Detection on Surfaces and in Caco-2 Cells of Campylobacter 
jejuni Cells Transformed with New gfp, yfp, and cfp Marker Plasmids. Appl. 
Environ. Microbiol. 66:5426-5436. 
25. Olson, C. K., S. Ethelberg, W. v. Pelt, and R. V. Tauxe. 2008. Epidemiology of 
Campylobacter jejuni Infections in Industrialized Nations, p. 163-189. In I. 
Nachamkin, C. Szymanski, and M. Blaser (ed.), Campylobacter, 3rd ed. ASM 
Press, Washinton DC. 
26. Palmer, S. R., P. R. Gully, J. M. White, A. D. Pearson, W. G. Suckling, D. M. 
Jones, J. C. Rawes, and J. L. Penner. 1983. Water-borne outbreak of 
campylobacter gastroenteritis. Lancet 321:287-90. 
27. Parkhill, J., B. W. Wren, K. Mungall, J. M. Ketley, C. Churcher, D. Basham, 
T. Chillingworth, R. M. Davies, T. Feltwell, S. Holroyd, K. Jagels, A. V. 
Karlyshev, S. Moule, M. J. Pallen, C. W. Penn, M. A. Quail, M. A. 
Rajandream, K. M. Rutherford, A. H. M. van Vliet, S. Whitehead, and B. G. 
Barrell. 2000. The genome sequence of the food-borne pathogen Campylobacter 
jejuni reveals hypervariable sequences. Nature 403:665. 
28. Pei, D., and J. Zhu. 2004. Mechanism of action of S-ribosylhomocysteinase 
(LuxS). Current Opinion in Chemical Biology 8:492. 
29. Raffa, R. B., J. R. Iannuzzo, D. R. Levine, K. K. Saeid, R. C. Schwartz, N. T. 
Sucic, O. D. Terleckyj, and J. M. Young. 2005. Bacterial Communication 
("Quorum Sensing") via Ligands and Receptors: A Novel Pharmacologic Target 
for the Design of Antibiotic Drugs. J Pharmacol Exp Ther 312:417-423. 
30. Rajan, R., J. Zhu, X. Hu, D. Pei, and C. Bell. 2005. Crystal Structure of S-
Ribosylhomocysteinase (LuxS) in Complex with a Catalytic 2-Ketone 
Intermediate. Biochemistry 44:3745-3753. 
31. Ren, D., L. A. Bedzyk, R. W. Ye, S. M. Thomas, and T. K. Wood. 2004. 
Stationary-Phase Quorum-Sensing Signals Affect Autoinducer-2 and Gene 
Expression in Escherichia coli. Appl. Environ. Microbiol. 70:2038-2043. 
32. Ruiz-Palacios, G. M. 2007. The health burden of Campylobacter infection and 
the impact of antimicrobial resistance: playing chicken. Clin Infect Dis 44:701-3. 
33. Ruzheinikov, S. N., S. K. Das, S. E. Sedelnikova, A. Hartley, S. J. Foster, M. 
J. Horsburgh, A. G. Cox, C. W. McCleod, A. Mekhalfia, and G. M. 
41 
Blackburn. 2001. The 1.2 A structure of a novel quorum-sensing protein, 
Bacillus subtilis LuxS. Journal of Molecular Biology 313:111. 
34. Schauder, S., K. Shokat, M. G. Surette, and B. L. Bassler. 2001. The LuxS 
family of bacterial autoinducers: biosynthesis of a novel quorum-sensing signal 
molecule. Molecular Microbiology 41:463-476. 
35. Sperandio, V. 2007. Novel approaches to bacterial infection therapy by 
interfering with bacteria-to-bacteria signaling. Expert Rev Anti Infect Ther 5:271-
6. 
36. Sun, J., R. Daniel, I. Wagner-Dobler, and A.-P. Zeng. 2004. Is autoinducer-2 a 
universal signal for interspecies communication: a comparative genomic and 
phylogenetic analysis of the synthesis and signal transduction pathways. BMC 
Evolutionary Biology 4:36. 
37. Surette, M. G., and B. L. Bassler. 1998. Quorum sensing in Escherichia coli and 
Salmonella typhimurium. PNAS 95:7046-7050. 
38. Wang, Y., and D. E. Taylor. 1990. Natural transformation in Campylobacter 
species. J Bacteriol 172:949-55. 
39. Yao, R., R. Alm, T. Trust, and P. Guerry. 1993. Construction of new 
Campylobacter cloning vectors and a new mutational cat cassette. Gene 130:127-
30. 
40. Zhu, J., E. Dizin, X. Hu, A. S. Wavreille, J. Park, and D. Pei. 2003. S-
Ribosylhomocysteinase (LuxS) Is a Mononuclear Iron Protein. Biochemistry 
42:4717-4726. 
41. Zhu, J., R. Patel, and D. Pei. 2004. Catalytic Mechanism of S-
Ribosylhomocysteinase (LuxS): Stereochemical Course and Kinetic Isotope 
Effect of Proton Transfer Reactions. Biochemistry 43:10166-10172. 
42. Zhu, J., and D. Pei. 2008. A LuxP-based fluorescent sensor for bacterial 
autoinducer II. ACS Chem Biol 3:110-9. 
 
 
42 
Figure legends 
 
Figure 1.  
 
AI-2 activities in various C. jejuni strains and constructs. 
 
A: Bioluminescence activity of 81116AI2- and AI2-(pLuxS) compared to the positive 
control strains Campylobacter jejuni 11168 and Vibrio harveyi BB152.  Each bar 
represents the average of three replicates with standard deviation. MH both is shown as a 
negative control.  BB152 is the positive control. B: AI-2 production in 81116 variants.  
81116AI2-, a laboratory strain with the G92D mutation in LuxS (AI-2 negative);  AI2-
(p256G), a 81116AI2- derivative with a shuttle vector carrying a luxS gene in which the 
G92D mutation is reverted; 81116AI2+, a 81116 variant with no mutation in luxS (AI-2 
positive); and MH Broth, culture media serving as a negative control for AI-2 activity. 
 
 
Figure 2.  
 
AI-2 concentrations in the culture supernatants of 81116AI2- and 81116AI2+, as a 
function of time. 
 
Figure 3. 
 
Sequence alignment of representative luxS genes from different bacterial species. 
Highlighted amino acids are mutated in the 81116 (bottom row) compared to the 
published 11168 sequence (2nd from bottom). “X” denotes the site of amino acid 
substitutions.  Proteins used in the sequence alignment are as follows (Protein 
Information Resource database ID numbers are shown in parentheses, with GenBank ID 
numbers given for ST, VH, and BH): HP, Helicobacter pylori (C71973); DR, 
Deinococcus radiodurans (D75280); HI, Haemophilus influenzae (G64008); BB, 
Borrelia burgdorferi (BB0377); CP, Clostridium perfringens (T43793); NM, Neisseria 
meningitides (G81963); ST, Salmonella typhimurium (AAF73475.1); VH, Vibrio harveyi 
(AAD17292.1); EC, Escherichia coli (H65048); VC, Vibrio cholerae (F82309); BS, 
Bacillus subtillis (A69994); and BH, Bacillus halodurans (BAB07072.1).11168, C. jejuni 
ATCC 11168; 81116AI2-, Campylobacter jejuni strain 81116 (AI-2 negative); 
81116AI2+, C. jejuni strain 81116 (AI-2 positive). 
 
Figure 4. 
 
 Production and functional characterization of recombinant LuxS proteins. 
A: SDS-PAGE gel of recombinant LuxS proteins from 81116AI2- and 81116AI2+.  Lane 
1: rLuxS- (expected MW=18.1 kD) from 81116AI2-; Lane 2: rLuxS+ (expected 
MW=18.1 kD) from 81116AI2+; and lane 3, molecular mass markers. B: Enzymatic 
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activity of the recombinant LuxS proteins measured by Vibrio harveyi bioluminescence 
assay.  SRH alone with no enzyme provides a negative control.  BB152 is cell-free 
supernatent of V. harveyi BB152 as a positive control.  
 
Figure 5. 
 
 Enzymatic activities of the recombinant LuxS proteins. 
A. Paired homocysteine and AI-2 data from the recombinant LuxS proteins. rLuxS+ is 
the recombinant LuxS protein from 81116AI2+ and rLuxS- is the recombinant LuxS 
protein from 81116AI2-. Black bars represent the homocysteine levels measured using 
the DNTB reaction measured by Absorbance at 412 nm (right axis).  The grey bars 
represent the AI-2 values measured by V. harveyi bioluminescence (left axis). Values for 
each sample were measured on split samples.  
 
Figure 6.  
 
Circular dichroism spectra of the rLuxS+ and rLuxS- recombinant proteins along 
with the buffer spectra.  The two protein spectra essentially overlay each other 
identically throughout the spectra. 
 
Figure 7. 
  
AI-2 and SRH levels of various cultures.  The first 6 columns depict the cell-free 
supernatant AI-2 concentrations of cultures as a reference for endogenous LuxS activity.  
The four columns labeled boiled are cell-free supernatant post-boiling which destroys AI-
2 activity.  Finally the last 4 columns show the AI-2 activity produced in the presence of 
exogenous rLuxS+ recombinant protein which provides a semi-quantitative measure of 
extracellular SRH levels. 
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Tables 
Table 1. Bacterial strains and plasmids used in this study 
 
Bacterial Strains Description Reference 
81116AI2- A variant of C. jejuni 81116 
negative with AI-2 
This study 
 
LuxS-   81116AI2- LuxS insertional 
mutant  
This Study 
AI2-(pLuxS) 81116AI2- with plasmid 
encoded 11168 LuxS 
This Study 
AI2-(p256G) 81116AI2- with plasmid 
encoded site directed 
revertant of 81116AI2- 
LuxS ORF 
This Study 
81116AI2+ C. jejuni 81116 positive 
with AI-2   
(26) 
11168   C. jejuni NCTC 11168 (27) 
11168∆luxS  11168 mutant with kanR 
inserted into luxS  
This Study 
BB170   AI-2 reporter strain; 
luxN::Tn5 
(4) 
BB152  AI-1-, AI-2+; luxM::Tn5 (3) 
 
Plasmids   
pRY111 E. coli-Campylobacter 
shuttle plasmid, KanR 
(39)    
puc256G puc19 plasmid containing 
site directed revertant 
This Study 
pRY256G pRY111 backbone with site 
directed revertant LuxS 
This Study 
 
 
 
 
 
 
 
 
 
 
52 
Table 2 
Primers used in this study 
 
Primers Sequence Target Gene 
Cj1198F1 GTTGGATCCCCATTATTAGACAGCTTTAAAGT luxS 
Cj1198R3 TAATCTGCAGTTTAAGCATTCTCGAGTTTT luxS 
LuxSF4 ACCTAAGGGTGATGATATTA luxS 
LuxSR4 GCTTAATCATTTAAAAAATAA luxS 
KanF  TTAAGCTTGCATCGATGAATTGTGTCTCAAAA KnR 
KanR  TTAAGCTTGGTGGACCAGTTGGTGATTT KnR 
luxSF7 TAGTCTAGATCATTTAAAACAGGCAAAGC luxS 
luxSR9 GTCCTGCAGCACATCTCGCACATCAGTT luxS 
luxS256G P-GTTGTCGCACGGGTTTTTATATGAG luxS 
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Chapter 3: 
The role of LuxS in the fitness and virulence of Campylobacter jejuni. 
Abstract 
 The s-ribosylhomocysteinase enzyme encoded by luxS is important for s-
adenosylmethionine (SAM) recycling and the production of the quorum sensing 
compound autoinducer-2 (AI-2). Previous studies on Campylobacter jejuni have 
demonstrated the role of LuxS in motility, cytolethal distending toxin production and 
agglutination, however its direct involvement in mediating fitness and virulence has not 
been reported.  In this study we demonstrate a direct role of luxS in both bacterial fitness 
and virulence in animal hosts.  Competitive fitness experiments were conducted by orally 
inoculating broiler chickens with 5x106 viable C. jejuni organisms.  Birds were mono-
inoculated with either W7 (strain NCTC 11168) or its LuxS mutant (W7∆luxS) or 
simultaneously inoculated with equal doses of both strains.  Cecal colonization was 
quantitatively measured at 5-7 day intervals following inoculation. To evaluate virulence, 
a guinea pig abortion model was utilized.  Pregnant guinea pigs between 19-21 days of 
gestational age were inoculated orally with 1x109 organisms.  Three groups were 
inoculated with either the wild-type IA3902 strain (IA3902 group), its luxS mutant 
(IA3902∆luxS group) or the mutant’s isogenic complement (IA3902+luxS group).  
Abortions were observed for a 21 day period at which time all remaining guinea pigs 
were necropsied and cultured. In a separate experiment the wild-type IA3902 strain and 
IA3902∆luxS were inoculated into pregnant guinea pigs via the intraperitoneal route. 
Although the wild-type and luxS mutant strains were both able to colonize the 
chickens to similar levels when inoculated separately, the co-inoculation of the two 
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strains resulted in rapid outcompetition of the luxS mutant by the wildtype. Mutagenesis 
of the luxS gene resulted in a complete loss of virulence in the guinea pig model with no 
evidence of fetal/placental infection.  The isogenic complement restored abortion and 
fetal/placental infection rates comparable or above that of the wild-type strain. 
Furthermore, inoculation via the intraperitoneal route failed to demonstrate the loss of 
virulence suggesting that the defect in virulence is likely associated with colonization 
and/or translocation out of the intestine.  These studies provide direct evidence in the 
animal host that LuxS plays an important role in competitive fitness and virulence of C. 
jejuni.   
Introduction 
Campylobacter jejuni is a leading cause of food borne bacterial enteritis in the 
United States and worldwide.  Generally it is associated with self-limiting enteritis that is 
indistinguishable from other bacterial causes of diarrhea including Salmonella and 
shigellosis, however it can also cause extra-intestinal infections, such as bacteremia and 
abortion (2). In severe cases of campylobacteriosis, the use of antimicrobial therapy, most 
commonly the macrolide and fluoroquinolone classes, helps to shorten the duration of 
disease and minimize secondary infections (2). Further rationale for antimicrobial therapy 
is provided by the fact that a subpopulation of patients exhibit long-term sequella to the 
infection with reactive arthritis and Guillain-Barré syndrome being the most common 
manifestations (2).  In recent years the rising incidence of antimicrobial resistances in C. 
jejuni to both macrolides and fluoroqinolones has prompted concerns over the use of 
these agents in food producing animals and the future utility of these compounds in 
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disease therapy (2).  In a recent registry based cohort study it was determined that 
patients with fluoroquinolone resistant strains of C. jejuni had a roughly 6-fold higher 
risk of a post infection adverse event within 30 days of sample submission compared to 
patients with fluoroquinolone sensitive, macrolide sensitive strains.  Similarly the 
investigators demonstrated a roughly 5-fold increased risk of adverse events in patients 
with macrolide resistant strains (10).  These findings highlight the clinical consequences 
of antimicrobial resistant C. jejuni and demonstrate the need for additional research 
focused on identification of alternate molecular targets that may be useful in therapeutic 
interventions of resistant C. jejuni strains.   
Despite nearly 30 years of research, the pathogenic mechanisms and virulence 
factors responsible for the colonization and systemic dissemination of C. jejuni infections 
remain poorly understood.  Recent studies have demonstrated that the colonization of C. 
jejuni is a complex event involving multiple factors and pathogen-host interactions (1, 4, 
5, 8, 9, 11, 14, 16). Intra- and interspecies competition results in comparative fitness 
advantages/disadvantages and can functionally result in a outcompeting of strains in a 
local ecology.  While a couple of specific genes and single nucleotide polymorphisms 
(SNPs) have been associated with this competitive fitness phenomenon the role of many 
virulence factors in the process remain unclear (17). Additionally, the detailed 
mechanisms responsible for initial translocation of C. jejuni across the gastrointestinal 
mucosa and the subsequent movement and seeding of distant organs have not been well 
described.   With an increasing incidence of treatment failures resulting from antibiotic 
resistant isolates there is a vital need for an improved understanding of the pathogenic 
mechanisms responsible for the disease manifestations of this organism.   
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 One target for therapeutic control being explored in a variety of bacterial species 
is the autoinducer-2 (AI-2) mediated quorum sensing pathway.  This system has been 
demonstrated to play a role in cell-to-cell communication responsible for expression of 
virulence in many bacterial organisms (18). It is known that C. jejuni produces functional 
AI-2 and that mutagenesis of the luxS gene results in decreases in motility, agglutination, 
and cytolethal distending toxin production (6, 7, 12, 13).  Recently, it was reported that 
LuxS mutant strains have a decreased potential for colonization of the chicken intestine, 
(19) however it is unknown if LuxS contributes to Campylobacter adaptation in the 
intestinal tract and if it affects the virulence of this pathogenic organism. The purpose of 
this study was to evaluate the competitive fitness of C. jejuni luxS mutants in competition 
with the wildtype strain and to determine the effect of LuxS mutagenesis on the in vivo 
pathogenicity of C. jejuni as an abortion agent in pregnant guinea pigs. Our results clearly 
demonstrate that mutagenesis of luxS results in a less fit isolate that is rapidly and almost 
completely outcompeted when co-inoculated with the wildtype strain.  Furthermore, luxS 
mutant strains of C. jejuni were completely attenuated in the guinea pig abortion model 
when inoculated via oral gavage, suggesting that this gene does play a significant role in 
the pathogenesis of Campylobacter associated abortions.  These findings provide 
compelling evidence that the luxS gene is important for pathogenicity and fitness of C. 
jejuni and that it may be a potential target for bacterial control.   
 
Materials and Methods 
Bacterial Strains and Growth 
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 Campylobacter jejuni strains were grown in Mueller-Hinton broth or agar in a 
microaerophilic (5% O2, 10% CO2 and 85% N2) environment and incubated at 42 ˚C.   
Chicken studies were performed using the wildtype strain W7 (a motile clone of NCTC 
11168) and its isogenic LuxS mutant (W7∆luxS).  For competitive fitness experiments 
the strains were grown for 16 hours on MH agar plates, harvested into MH broth, 
adjusted to OD600 of 0.1 and equal volumes of each strain were mixed in a 1:1 ratio prior 
to inoculation (0.2 mL per bird).  Mono-inoculated birds were given an equal dose (0.1 
mL) of the individual cultures.  For the guinea pig abortion model C. jejuni strain 
IA3902, its LuxS mutant (IA3902∆LuxS), and a chromosomally encoded complement 
strain (IA3902+LuxS) were cultured as described above.  When necessary for selection, 
the strains were grown on MH agar containing either kanamycin (30 µg/ml) or 
chloramphenicol (4 µg/ml).   Quantitative fecal cultures were performed by spreading 
100 µL of culture material (serially diluted fecal material in MH broth) on MH agar 
containing Campylobacter selective and supplemental additive (Oxoid) (MH+Sel+Supp).  
C. jejuni colonies were identified based on morphological appearance and a portion of the 
representative colonies were confirmed using PCR and biochemical testing.  For culture 
of bile and blood two to three drops of the fluid were placed on the MH+Sel+Supp plates 
and distributed using a sterile spreader.  Fecal swabs were directly plated using the swab.  
Placenta, uterus and fetal lung/liver homogenate were cultured by sampling the tissues 
with a sterile cotton swab and then using the swab to streak the MH+sel+supp plate.  C. 
jejuni colonies were identified and confirmed as described above.  E. coli strains used for 
genetic manipulation were grown on Luria-Bertani (LB) broth or agar containing 
kanamycin or chloramphenicol as necessary for selection. 
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Recombinant DNA Techniques 
Natural transformation of the W7 and IA3902 strains with genomic DNA from a 
previous LuxS mutants developed in our laboratory was utilized to construct the 
W7∆luxS and IA3902∆luxS strains, respectively, as previously described (Chapter 2 of 
this thesis).  For complementation studies a copy of the luxS gene (including the putative 
promoter) was inserted into W7∆luxS by homologous recombination into the intergenic 
region of the ribosomal RNA gene operon as described by Karlyshev and Wren with 
some modifications (15). Briefly, the rDNA sequence was amplified and cloned into the 
pGEM-T Easy plasmid (Promega), which was subsequently digested with MfeI.  The 
chloramphenicol acetyltransferase gene was amplified from pUOA18 (22) and inserted 
into the digested plasmid to produce pRRC.  The luxS gene, along with 500 bp of its 
upstream sequence containing the putative promoter region, was cloned into a XbaI site 
of pRRC located upstream of the resistance determinant.   This plasmid was then utilized 
as a suicide vector and electroporated into W7∆luxS. Homologous recombination of this 
construct with the chromosomal ribosomal RNA gene cluster resulted in insertion of a 
wild-type copy of the luxS gene into W7∆luxS. The transformants were selected using 
chloramphenicol and confirmed by AI-2 assay using the Vibrio harveyi bioluminescence 
bioassay.  PCR and sequence analysis (data not shown) confirmed that the expected 
mutation and complementation constructs were present. 
 
AI-2 Bioluminescence Assay 
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The Vibrio harveyi bioluminescence assay was performed as previously described  
(21). Luminesence was measured every 15 minutes for 6 hours and the values (relative 
light units; RLU) utilized for analysis were those occurring at the time point with the 
lowest RLU value for the negative control wells.   
 
Chicken colonization and competitive fitness 
For colonization studies 3-5 day old Ross X Cobb chicks were obtained from a 
commercial hatchery.  All chicks were screened and found to be negative for 
Campylobacter shedding upon arrival using cloacal swabs cultured on MH+sel+supp 
media.  Chicks were inoculated by oral gavage with 100 µL of bacterial suspension 
containing a total of approximately 1x107 cfu/mL of either the wildtype (W7) or mutant 
strain (W7∆luxS). Each group contained 12 chickens and groups were housed in separate 
rooms with no contact.   Randomly selected birds were sacrificed at predetermined time 
intervals using carbon dioxide asphyxiation.  Necropsy was promptly performed and 
cecal contents were aseptically collected and placed on ice until further processing.  
Samples were subject to 10-fold serial dilution and cultured as described above.  For 
competitive fitness experiments the bacterial suspensions used for the monoinoculated 
birds were mixed in a 1:1 ratio.  Chicks in the competitive fitness groups were orally 
gavaged with 200 µL of mixed bacterial suspension to receive a dose of each strain 
similar to the mono-inoculated birds. Cecal contents were collected and processed as 
described above. To confirm that there was not cross-contamination of the bacterial 
strains between treatment groups, representative isolates from each group were confirmed 
to be the inoculated strain by antimicrobial selection.  All animal experiments conducted 
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as part of this manuscript were approved by and in accordance with the Institutional Care 
and Use Committee prior to initiation of the project. 
 
Guinea pig abortion model 
Time-bred female Hartley guinea pigs were obtained from a commercial supplier 
at 20-24 days of pregnancy.  Animals were allowed a 5-day acclimation period and fecal 
swabs were collected to confirm Campylobacter-negative status prior to inoculation.  
Three strains were used for inoculation in the guinea pig studies, including IA3902, a 
highly virulent ovine abortion isolate (20), its luxS mutant (IA3902∆luxS), and in the oral 
challenge model a chromosomally encoded luxS complement of the IA3902∆luxS strain 
(IA3902+luxS). Inoculation solution was prepared by growing strains as a lawn on MH 
agar plates for 16 hours at 42 ˚C.  The bacterial cells were harvested and resuspended in 
MH broth, which was adjusted to OD600 approximately 0.5 to provide an inoculum of 
approximately 1x108 cells/mL. Each guinea pig was administered 1.0 mL of inoculum by 
oral gavage. Guinea pigs were observed twice daily for signs of vaginal bleeding, aborted 
fetuses or significant weight loss.   At the first sign of impending abortion the guinea pigs 
were euthanized using an intraperitoneal injection of pentobarbital sodium and phenytoin 
sodium (Beuthanasia-D).  Animals were subjected to an immediate necropsy with 
collection of uterus, placenta, fetal liver and lungs, blood, bile, and fecal material for 
Campylobacter culture.  Those guinea pigs having not previously aborted at 21 days post 
inoculation were euthanized and necropsied as above.  During the study, guinea pigs 
were housed in individual cages with ad libitum access to food and water.  Cages were 
grouped by inoculation strain.  For intraperitoneal inoculation the procedure was 
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essentially identical to above except that 1 ml of 1x106 cells/mL suspension were injected 
into the abdominal cavity instead of the oral gavage.  Guinea pigs were monitored and 
necropsied as described above with the exception that for this portion of the study up to 
three placentas (when available) were pooled and used for bacterial enumeration.  
Briefly, the pooled placentas were weighed and diluted one to one with MH broth.  They 
were then macerated and mixed using a stomacher.  The macerated samples were allowed 
to sit briefly and the supernatent was used in a 10-fold serial dilution prior to plating on 
MH+sel+sup media for enumeration. 
 
Motility 
All strains used in the experiment were assessed for motility using semi-solid MH 
agar media as previously described (Chapter 2). Briefly, the strains were grown overnight 
and OD600 adjusted to 0.5.  A single stab inoculation was made in the center of the plate 
and incubated at 42˚ C for 30 hours.  The distance of swarming motility was measured at 
the widest portion of the swarm halo.  
 
Statistics 
For simultaneous comparison of mono-inoculated and co-inoculated colonization 
rates of chickens, an ANOVA analysis was performed.  If the null hypothesis that the 
groups were identical was rejected, then a Bonferroni’s post-test for each of the 
individual paired groups was performed with the null hypothesis being that the 
colonization rates were identical between comparison groups. For simultaneously testing 
for a difference in the incidence of fetal/placental infection between all three comparison 
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groups (ie. wildtype, luxS mutant and complement) a Pearson’s chi-squared test was 
utilized.  Due to the low number of observations in some of the groups associated with 
lower then expected pregnancy rates, a simulation was performed with 100,000 iterations 
using the R statistical package to determine the p value. (R, R Foundation for Statistical 
Computing, Austria).  Subsequently a Fisher’s-exact test was then used to test for a 
difference between all potential combinations of group pairs using R.  For this component 
the null hypothesis tested was that the true odds ratio for the two groups was 1.  In all 
circumstances a p-value less then 0.05 is considered significant and less then 0.01 is 
considered very significant. 
 
Results 
AI-2 activity and motility   
All wildtype and mutant strains were evaluated using the Vibrio harvyi 
bioluminescence assay and confirmed to have the expected AI-2 phenotype  (Figure 1).  
The wildtype strains (W7 and IA3902) were both found to have luminescent values 
comparable to the positive control strain, demonstrating active AI-2 production.  In 
contrast, both mutant strains (W7∆luxS and IA3902∆luxS) had baseline luminescence 
comparable to the negative control (MH broth alone).  Interestingly the complement 
strain (IA3902+luxS) had bioluminescence values significantly higher than both the 
wildtype and positive control strains.  
All isolates were screened for motility prior to use in the animal studies.  All 
isolates were found to be highly motile and the average motility observed at 30 hours 
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post inoculation did not vary between isolates based on an ANOVA analysis (Figure 2).  
As previously described the luxS mutants had a trend towards decreased motility when 
compared to the wildtype strains, however this trend did not result in statistical 
significance. 
 
Chicken colonization and competitive fitness 
To assess the role of luxS and AI-2 in the colonization of chickens, two non-
concurrent experiments were performed.  In the first, the wildtype W7 and its luxS 
mutant (W7∆luxS) strains were used to mono-inoculate 3-5 day old chicks.  As 
demonstrated in figure 3A, both of the mono-inoculated W7 and W7∆luxS groups were 
colonized to similar levels at both the 5-day and the 10-day post-inoculation time point. 
In the co-inoculation study of experiment 1 (figure 3B), two of the birds euthanized at 
day 5 did not grow any W7 strain, which resulted in a 1 log lower average colonization 
for the W7 group compared to the mutant group for that time point. In contrast the 10-day 
PI co-inoculation data demonstrated a 1 log decrease in colonization rate for the 
W7∆luxS group.  Unlike the difference observed in the 5 day co-inoculation data, the 
difference at 10 days was observed with all birds being culture positive.  A one-way 
ANOVA test failed to detect a significance of differences between the groups at any 
given time point.   
 Given that a longer observation period might be required to see a fitness defect 
and that there appeared to be a trend towards decreased fitness of the W7∆luxS strain at 
10 days PI (Figure 3B), we repeated the chicken study with a prolonged observation 
period.  In the second experiment, additional chicks were added to the study design to 
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allow for weekly sampling over four weeks.  Similar to the first study the mono-
inoculated groups were colonized rapidly by the wildtype or mutant strain and remained 
steadily colonized for the duration of the project (figure 3C). There were no statistically 
significant differences observed between the two groups at any given time points 
(p=0.47).  In the co-inoculation group (figure 3D), the mutant strain (W7∆luxS) was 
outcompeted by the wildtype strain starting at 8 DPI (p=0.0001).  Pairwise comparisons 
of the competition pair using Bonferroni’s Multiple Comparison Test demonstrated a 
statistically significant difference between W7 and W7∆luxS at all time-points with 
W7∆luxS consistently having a lower colonization rate.  The mean log difference and 
95% confidence intervals for that difference at each of the time points are as follows: 
4.929 (1.946-7.911) for 8 dpi, 4.782 (1.8-7.765) for 14 dpi, 7.320 (4.338-10.3) for 21 dpi 
and 6.970 (4.158-9.782) for 28 dpi (Fig. 3D).   
 
Guinea Pig Study 
In the first guinea pig pathogenesis study three groups of 12 time-bred guinea pigs 
were inoculated orally with one of three strains: IA3902, IA3902∆luxS or IA3902+luxS.  
Given the stage of gestation when the animals were purchased the provider was unable to 
guarantee pregnancy in every guinea pig and accordingly some of the animals were 
determined to have not been pregnant based upon a lack of weight gain during the study 
and necropsy at the conclusion of the study. Three guinea pigs in the IA3902, 5 guinea 
pigs in the IA3902∆luxS group and 2 guinea pigs in the IA3902+luxS group were 
excluded from the data analysis due to a non-pregnant status. Additionally one animal in 
the IA3902∆luxS group aborted on day 19 of the study but was negative for C. jejuni on 
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all cultures (cecum, bile, blood, uterus, fetus, placenta, and fetal stomach contents) and 
had histopathology changes not characteristic of C. jejuni induced abortions.  In light of 
these findings it was deemed that this abortion was unlikely to be associated with the test 
organism and the data for that animal was not utilized in subsequent analyses. The results 
showed that mutagenesis of luxS resulted in a complete attenuation of the virulence of 
IA3902 as a cause of abortion and that subsequent complementation of the gene restored 
virulence to the level of the wildtype strain (Figure 4). A significant difference was 
observed between the IA3902 and IA3902∆luxS groups (p=0.034) and a very significant 
difference was observed between the IA3902∆luxS and IA3902+luxS complement 
groups (p=0.0023).  No differences were observed between the wildtype and complement 
groups (p=0.34). This data demonstrates that the mutagenesis of luxS attenuates the 
ability of C. jejuni to cause fetal/placental infections in the guinea pig model, and that 
restoration of luxS function by gene complementation fully restores virulence.   
To facilitate understanding the cause of this loss of virulence we evaluated the 
fecal shedding patterns of the three groups throughout the study.  Fecal carriage results 
revealed that the IA3902∆luxS strain was not able to colonize the inoculated guinea pigs 
and that the defect in colonization was fully complemented in the IA3902+luxS strain 
(Table 1). At 3 days post-inoculation, 92% of the IA3902 group and 75% of the 
IA3902+luxS group were positive for fecal shedding of the inoculation strain while only 
8% of the IA3902∆luxS guinea pigs were shedding C. jejuni. At all later time points there 
were no IA3902∆luxS found in the feces of the inoculated guinea pigs while the shedding 
remained above 75% in the two remaining groups.  Given that these results were not 
quantitative and did not include enrichment it is difficult to rule out the possibility of low 
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level carriage by the IA3902∆luxS group, however there is clearly a trend towards lower 
carriage rates in that group.  
 The results of the C. jejuni culture performed at the time of necropsy are provided 
in Figure 5A.  For the IA 3902 group the recovery rates of individual tissue samples 
ranged from 25% for bile up to 75% for feces.  The placenta, feces and fetal lung/liver 
homogenate showed the highest recovery rates with more than 50% of the sample 
positive at the time of necropsy.  A similar trend was seen in the IA3902+luxS strain 
which had recovery rates of individual tissues ranging from 16% for bile and blood up to 
78% for the fetal liver/lung homogenate.  The recovery rates for tissues from the 
IA3902+luxS group roughly mirrored those observed in the wildtype IA3902 group.  In 
contrast, no tissue samples collected at the time of necropsy from any of the 
IA3902∆luxS animals yielded positive culture of C. jejuni (Figure 5A).  The semi-
quantitative culture results for each tissue are also presented in Table 2.  Based on these 
results several general themes can be identified.  Blood and bile tend to have lower rates 
of isolation and tend to have lower bacterial counts on culture.  Such a finding is not very 
surprising given the liquid nature of these samples and the less conducive environment 
for colonization and growth.  In contrast, the uterus, fetus and placental samples appear to 
yield higher CFU counts in both the IA3902 and IA3902+luxS strains.  This is 
particularly true for placenta where all cultured samples yielded greater than 1000 
CFU/gram of placenta. 
 
Guinea Pig Intraperitoneal Challenge Results 
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 Given the complete ablation of the abortion phenotype in the luxS mutant strain, 
we were interested in further defining the general stage of pathogenicity responsible for 
the defect.  In order to test the luxS mutant’s ability to induce abortions once it reaches 
the systemic circulation we repeated the study using an intraperitoneal inoculation route.  
This inoculation route resulted in induction of bacteremia as evidenced by the positive 
blood cultures obtained from the first guinea pig to abort at 18 hours post-inoculation and 
from many of the guinea pigs at the time of abortion (Figure 5B and Table 3).  In 
comparison to the oral inoculation group the recovery rates of C. jejuni from various 
tissue samples were higher in the intraperitoneal challenge model (Figure 5B).  The 
recovery rate for the IA3902 strain ranged from 44% for blood up to 100% for uterus, 
fetal lung/liver homogenate and placenta.  Similarly, the recovery rate of the 
IA3902∆luxS strain ranged from 50% in bile up to 100% for uterus, fetal liver/lung 
homogenate and placenta (Figure 5B). Like the semi-quantitative data collected in the 
oral challenge, the general trend for higher CFU counts on uterus, placenta and fetal 
lung/liver homogenate were also observed following intraperitoneal challenge.  The 
intraperitoneal challenge did result in a shift of more of the blood and bile samples into 
the moderate and high recovery ranges which would be expected given that it bypasses 
the necessity of translocation across the intestinal mucosal (Table 2). Following 
intraperitoneal challenge both the abortion and fetal-placental infection rates were 
essentially identical between the IA3902 and IA3902∆luxS groups over the period of the 
study and were not found to be statistically different (Figure 6), indicating that the luxS 
mutant was fully capable of causing abortion when given intraperitoneally. 
68 
 Based on the high level of recovery of significant bacterial numbers from placenta 
we were interested in further quantifying the bacterial load carried by the placenta in the 
guinea pigs challenged intraperitoneally.  Using quantitative bacterial culture methods we 
demonstrate that C. jejuni counts range from 3x106 CFU/gram of placenta up to 2.4x108 
CFU/gram for the IA3902 group (Figure 7). Similarly, the range of counts for the 
IA3902∆luxS group ranged from 5x106 up to 2.2 x108 CFU/gram of placenta.  
Interestingly, at 24 hours post-inoculation one guinea pig’s placenta contained 2.5 x 107 
CFU/gram of placental tissue, suggesting rapid colonization and replication of the 
organism in the placental environment.   
 
Discussion 
 This study provides the first evidence of a measurable fitness cost associated with 
the loss of luxS function as well as the first evidence for a role for this gene in the 
pathogenesis of C. jejuni.  While previous studies have demonstrated in vitro phenotypic 
changes in virulence factor expression or changes in non-pathogenic colonization we 
provide the first direct association of the luxS mutation with a measurable impact on in 
vivo pathogenesis using a guinea pig abortion model.   At the present time it remains 
unclear what the relative role of the two luxS functions, metabolically recycling SAM and 
producing AI-2, play in this decreased pathogenicity, however efforts to further define 
these roles are ongoing. 
The results of the mono-inoculated chicken studies demonstrate that individually 
the W7 and W7∆luxS isolates are capable of stably colonizing chicks to similar levels 
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and for similar durations.  These results are in contrast to the recent paper by Quinones et 
al where they observed a significant difference in colonization rates of monoinoculated 
chicks between the wildtype and luxS mutants of C. jejuni 81176 (19). The reasons for 
this inconsistency are unknown but could be associated with differences in wildtype 
strain colonization, differences in inoculation dose, or differences in motility.  We have 
found that a disproportionate number of isolates obtained following genetic manipulation 
of C. jejuni have severely compromised motility (unpublished data).  This finding is not 
exclusive to luxS but has been observed in multiple experiments with differing genes of 
interest.  As a result we screened all mutant strains for motility and eliminated isolates 
that were found to be non-motile.  In the case of luxS mutants utilized in this study we see 
a consistent reduction in motility following gene knock-out, as described previously.  
Since the motility can significantly affect the colonization rate, unknown changes in 
motility can confound colonization data.  An additional component of the explanation 
may involve the role of exogenous enteric AI-2 levels produced by the normal enteric 
flora that can possibly complement the AI-2 negative phenotype in-trans.  
 The competitive fitness experiments in chickens show a consistent outcompeting 
of the luxS mutant strain when co-inoculated with the wildtype strain.  Even with a limit 
of detection of 100 cfu/gram of cecal contents we were unable to obtain any W7∆luxS 
isolates in a significant number of co-inoculated chicks while the colonization levels of 
the wildtype strain were consistently 6-8 logs higher.  We hypothesize that this fitness 
disadvantage is associated with a mutifactorial process including decreased motility, 
decreased metabolic recycling of s-adenosylmethionine with its associated alterations in 
normal metabolism and possibly the loss of AI-2 mediated quorum sensing.  Although 
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the role of AI-2 mediated quorum sensing is purely speculative at the current time, 
ongoing research in our laboratory will help to further define the mechanistic role of 
quorum sensing in this fitness cost.  Given that the fitness disadvantage is observed in a 
model that should contain exogenous enteric levels of AI-2, we hypothesize that quorum 
sensing is not the only significant mechanism responsible for the loss of colonization. 
 Autoinducer-2 mediated quorum sensing has been linked to the regulation of 
many pathogenic mechanisms across a variety of species.  While the chick colonization 
model does provide a relevant system to study foodborne disease risk (i.e. the majority of 
human cases are believed to be linked to contaminated poultry), this model does not 
provide any measure of pathogenicity since the organism colonizes the chicken sub-
clinically.  In an effort to further define the role of luxS in the pathogenicity of C. jejuni 
we utilized a guinea pig abortion model previously described in our laboratory (3). This 
model provides a consistent and easily measured pathogenic outcome, namely 
fetal/placental infection and subsequent abortion.  Such a process is characteristic of C. 
jejuni abortion storms in small ruminants (sheep and goats) and when performed using 
oral inoculation also provides an indirect measure of the organisms ability to cross the 
enteric epithelium and disseminate systemically.  The last two points are relevant to 
human enteric disease and C. jejuni’s ability to result in systemic disease and post-
infection sequella such as Guillian Barre syndrome.   
In this study, mutagenesis of the luxS gene of IA3902 resulted in a complete 
ablation of the ability of the organism to result in fetal/placental infection and abortions 
following oral inoculation.  When the strain was complemented with a chromosomally 
encoded luxS gene located in an intergenic region the phenotype was completely restored.  
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These findings provide evidence for a necessary role of the luxS gene in the 
pathogenicity of C. jejuni following oral exposure.  Furthermore, the data would suggest 
that one explanation for this loss of pathogenicity was a decreased ability to colonize the 
guinea pig GI system in high numbers.  To determine if this decreased colonization rate 
was the primary source of difference we performed a second guinea pig experiment 
utilizing an intraperitoneal inoculation.  By bypassing the necessity for colonization and 
translocation of the bacteria across the GI cellular border we can assess the role of luxS in 
the systemic dissemination of the organism.  Based on the results of these studies it 
would appear that the primary defect in abortion induction occurs at the level of either 
colonization or translocation across the intestinal mucosa.  Once the luxS mutant becomes 
systemic it appears equally capable to the wildtype in inducing abortions. 
 The recovery rates of C. jejuni from tissue samples collected at necropsy 
demonstrate some interesting trends that may provide additional insight into the 
pathogenesis of C. jejuni associated abortions.  The most obvious of these trends is the 
complete lack of culture positive results from any of the tissue collected on guinea pigs 
inoculated with W7∆luxS via the oral route.  When the intraperitioneal route of 
inoculation was utilized the strain was readily isolated from tissues at similar rates and 
amounts to those of wildtype (Figure 6B and Table 2).  Collectively these results suggest 
that the loss of W7∆luxS’s ability to induce abortions and fetal/placental infections 
following oral challenge is associated with differences in pathogenesis prior to 
dissemination out of the intestine.  Once the organism becomes systemic it is capable of 
rapidly inducing bacteremia, placental infection and abortion.  The quantification of 
placental C. jejuni CFU/gram counts of 2x107  at less than 24 hours post-inoculation, 
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suggest rapid replication and colonization of the placental unit of the guinea pig.  
Clinically, the aborted placenta of sheep and goats is considered an important source of 
environmental contamination with C. jejuni and these very high levels of contamination 
would support this clinical finding, at least in the case of the guinea pig placenta.  
Furthermore, this finding provides insight into the rapid progression of placental 
involvement and abortion following exposure.  Epidemiologically, this is consistent with 
the “abortion storm” scenario commonly observed in clinical practice. Given the low 
numbers of placentas available for quantitation and the differences in incubation periods 
post inoculation we were unable to further compare the placental isolate rates for the two 
strains.  No obvious trends towards increasing bacterial counts occur with time post-
inoculation, however we cannot rule out such a trend with this limited data set  (Figure 
7). 
 The relatively lower recovery rates and CFU numbers from the bile and blood 
samples was a second general trend that was observed during both guinea pigs studies.  
We believe that the cause for this trend may be twofold.  First, these sites are likely less 
hospitable to bacterial growth than those observed in other tissues.  Although C. jejuni is 
capable of living in environments that contain bile conjugates, the concentration of these 
compounds in the gallbladder and concentrated bile is far above that observed in the 
small intestine and thus may play a role in limiting bacterial replication.  Likewise, the 
bacteria present in the blood are in direct contact with large numbers of innate and 
aquired immune effector cells and factors as well as being filtered through the liver 
immune network, potentially limiting their accumulation to large numbers.  Secondly, 
based on previous studies this particular strain appears to have a tissue specific tropism to 
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the fetal-placental unit (3).  This tropism combined with the solid tissue matrix for 
growth may allow for rapid replication and colonization before immune effector cells can 
effectively infiltrate the site.  Although the bacterial counts were still generally lower in 
blood and bile compared to the other tissues following intraperitoneal inoculation, they 
were higher than that observed following the oral challenge model.  Bacterial challenges 
given in the intraperitoneal space are rapidly carried by the lymphatic drainage into the 
systemic circulation.  The direct administration of a significant bacterial load via the 
intraperitoneal route likely results in higher bacterial counts in the blood than an 
administration route that requires the necessity of intestinal colonization and translocation 
prior to reaching the blood stream. 
 The results of the chicken studies presented in this paper clearly demonstrate that 
luxS mutants of C. jejuni have a competitive fitness disadvantage when inoculated with 
their wildtype parent strain.  Furthermore, mutagenesis of luxS results in a complete loss 
of virulence in the guinea pig abortion model and genetic complementation of the gene 
fully restores virulence.  Collectively, these results demonstrate that luxS and/or AI-2 are 
important for environmental adaptation and virulence of C. jejuni. The exact role of the 
dual luxS functions (as a metabolic enzyme and a quorum sensing molecule) in these 
adaptation and pathogenicity phenotypes remains unclear.  Ongoing experiments focused 
on the role of both the metabolic dysfunction and the quorum sensing mechanisms should 
provide further evidence of the mechanisms responsible for pathogenicity of C. jejuni. 
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Figure Legends 
Figure 1: 
Quantification of autoinducer-2 production by bacterial strains used in this study.  
Autoinducer-2 levels of the cell free supernatant of strains utilized in this study and 
measured by the bioluminescent Vibrio harveyi autoinducer -2 bioassay.  Values are 
reported as relative light units (RLUs).  Vibrio harveyi strain BB152 is the positive 
control and uninoculated MH media serve as a negative control. 
 
Figure 2: 
Motility of C. jejuni isolates utilized in this study.  Motility of study strains measured 
as the maximum diameter of swarming on semi-soft MH media following a 30-hour 
incubation.   
 
Figure 3: 
Cecal colonization of chickens by C. jejuni 
Results are reported as the log CFU count per gram of cecal contents.  Each symbol 
represents the data for a single bird and the horizontal line represents the average of the 
birds in a given group. Panes A and B are derived from the first chicken experiment and 
panes C and D are derived from the second chicken experiment,  A: Cecal colonization of 
C. jejuni following inoculation of pure culture of either W7 or W7∆luxS at 5 and 10 days 
post-inoculation.  B: Cecal colonization following co-inoculation with a 1:1 ratio of W7 
and W7∆luxS.  Culture results for the individual strains are represented in adjacent 
columns of the graph denoted by the same day of isolation.  C: Cecal colonization of C. 
jejuni following inoculation of pure culture of either W7 or W7∆luxS at 8, 14, 21 and 28 
days post inoculation.  D: Cecal colonization following co-inoculation with a 1:1 ratio of 
W7 and W7∆luxS.  Culture results for the individual strains are represented in adjacent 
columns of the graph denoted by the same day of isolation.   
 
Figure 4: 
Cumulative placental/fetal infection rate (pane A) and abortion rate (pane B) 
following oral inoculation of C. jejuni.  Placental/fetal infection was defined as a 
positive C. jejuni culture on one or more of the placenta, uterine or fetal samples 
collected at necropsy.  Abortion was defined as the identification of significant vaginal 
bleeding or expelled fetuses that were culture positive for C. jejuni.   
 
Figure 5: 
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Recovery rate of C. jejuni following oral (pane A) or intraperitoneal (pane B) 
inoculation of pregnant guinea pigs.  Recovery rates were calculated as the percent of 
cultured samples for a given tissue that were culture positive at the time of necropsy.  The 
individual number of samples cultured for each tissue varied based on the ability to 
aseptically collect the sample at necropsy.   
 
Figure 6:  
Cumulative placental/fetal infection rate (pane A) and abortion rate (pane B) 
following intraperitoneal inoculation of C. jejuni.  Placental/fetal infection was defined 
as a positive C. jejuni culture on one or more of the placenta, uterine or fetal samples 
collected at necropsy.  Abortion was defined as the identification of significant vaginal 
bleeding or expelled fetuses that were culture positive for C. jejuni.   
 
Figure 7: 
Quantitative C. jejuni culture of placental tissue derived from intraperitoneally 
inoculated pregnant guinea pigs.  The log count of the CFU/gram of placenta versus the 
day of necropsy following inoculation. Not all placentas were appropriate for bacterial 
quantification due to contamination by bedding material in cage.  
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Tables 
Table 1: Relative proportions of culture positive samples obtained following necropsy of 
pregnant guinea pigs orally inoculated with C. jejuni. 
 
Strain Proportion of Guinea Pigs Positive on Fecal Culture* 
 3 DPI 7 DPI 10 DPI 14 DPI Necropsy 
IA3902 11/12 7/9 6/9 5/6 8/12 
IA3902∆luxS 1/12 0/12 0/12 0/12 0/12 
IA3902+luxS 8/12 9/10 8/9 6/7 8/12 
* Values reported represent the number of samples with positive culture results/number 
of samples tested. 
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Table 2: Semi-quantitative recovery data from the oral inoculation guinea pig study 
Sample Source No. of culture-
positive 
samples* 
Low 
Recovery 
(<50 CFUs)† 
Moderate 
Recovery 
(50-1,000 
CFUs)† 
High 
Recovery 
(>1,000 
CFUs)† 
Blood 
     IA3902 
     IA3902∆luxS 
     IA3902+luxS 
 
5/12 
0/12 
2/12 
 
3/5 
0/0 
2/2 
 
1/5 
0/0 
0/2 
 
1/5 
0/0 
0/2 
Bile 
     IA3902 
     IA3902∆luxS 
     IA3902+luxS 
 
3/12 
0/12 
2/11 
 
3/3 
0/0 
2/2 
 
0/3 
0/0 
0/2 
 
0/3 
0/0 
0/2 
Feces 
     IA3902 
     IA3902∆luxS 
     IA3902+luxS 
 
8/12 
0/12 
8/12 
 
3/8 
0/0 
4/8 
 
2/8 
0/0 
3/8 
 
3/8 
0/0 
1/8 
Gravid Uterus 
     IA3902 
     IA3902∆luxS 
     IA3902+luxS 
 
5/12 
0/12 
8/12 
 
0/5 
0/0 
0/8 
 
1/5 
0/0 
2/8 
 
4/5 
0/0 
6/8 
Fetal Liver of lung (Pooled)‡ 
     IA3902 
     IA3902∆luxS 
     IA3902+luxS 
 
5/9 
0/7 
7/9 
 
1/5 
0/0 
2/7 
 
1/5 
0/0 
3/7 
 
3/5 
0/0 
2/7 
Placenta 
     IA3902 
     IA3902∆luxS 
     IA3902+luxS 
 
5/9 
0/7 
6/8 
 
0/5 
0/0 
0/6 
 
0/5 
0/0 
0/6 
 
5/5 
0/0 
6/6 
* Values reported represent the number of samples with positive culture results/number 
of samples tested. 
† Values reported represent the number of samples within that category/number of 
samples with positive culture results 
‡ Pooled= Samples from all fetuses of a specific guinea pig were pooled for microbial 
culture 
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Table 3: Semi-quantitative recovery data from the intraperitoneal inoculation guinea pig 
study 
Sample Source No. of culture-
positive 
samples* 
Low 
Recovery 
(<50 CFUs)† 
Moderate 
Recovery 
(50-1,000 
CFUs)† 
High 
Recovery 
(>1,000 
CFUs)† 
Blood 
     IA3902 
     IA3902∆luxS 
 
4/9 
5/8 
 
1/4 
4/5 
 
2/4 
1/5 
 
1/4 
0/5 
Bile 
     IA3902 
     IA3902∆luxS 
 
5/9 
4/8 
 
3/5 
0/4 
 
2/5 
4/4 
 
0/5 
0/4 
Feces 
     IA3902 
     IA3902∆luxS 
 
7/9 
8/9 
 
3/7 
3/8 
 
2/7 
4/8 
 
2/7 
1/8 
Gravid Uterus 
     IA3902 
     IA3902∆luxS 
 
7/7 
7/7 
 
1/7 
0/7 
 
1/7 
3/7 
 
5/7 
3/7 
Fetal Liver of lung (Pooled)‡ 
     IA3902 
     IA3902∆luxS 
 
6/6 
4/4 
 
0/6 
0/4 
 
0/6 
0/4 
 
6/6 
4/4 
Placenta 
     IA3902 
     IA3902∆luxS 
 
7/7 
7/7 
 
0/7 
0/7 
 
0/7 
0/7 
 
7/7 
7/7 
* Values reported represent the number of samples with positive culture results/number 
of samples tested. 
† Values reported represent the number of samples within that category/number of 
samples with positive culture results 
‡ Pooled= Samples from all fetuses of a specific guinea pig were pooled for microbial 
culture 
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Chapter 4: 
Transcriptomic and phenotypic changes associated with LuxS mutation 
or presence of AI-2  in Campylobacter jejuni 
 
Abstract 
 Quorum sensing is an important regulator of virulence and environmental 
adaptation in a variety of bacterial species.  Campylobacter jejuni has been demonstrated 
to produce autoinducer-2 (AI-2), the effector molecule of the widely distributed LuxS 
quorum sensing pathway that is conserved over a large number of gram positive and 
gram negative bacterial organisms.  Previous work with luxS mutants in C. jejuni has 
suggested that this enzyme may play important roles in motility, autoagglutination and 
biofilm formation, however a comprehensive evaluation of phenotypes conferred by 
LuxS has not been reported.  This paper details the application of a phenotypic 
microarray designed to evaluate roughly 2000 phenotypes in the C. jejuni wildtype and 
luxS mutant strains.  Furthermore, we evaluate the transcriptomic changes associated with 
both luxS mutagenesis and the addition of exogenous AI-2 using cDNA microarrays.  The 
collective results of the phenotypic and transcriptomic changes complement each other 
and suggest additional roles for LuxS and AI-2 in environmental adaptation to 
phosphorous, phospholipid biosynthesis, environmental information processing and 
selenium metabolism.  Additionally, several transcriptional regulator genes were found to 
be differentially transcribed including rpoN, the sigma-54 factor responsible for 
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regulation of flagellar biosynthesis.  The observed transcriptomic changes provide 
additional clues to the molecular mechanisms responsible for previously observed 
phenotypes and identify new phenotypes for additional study. 
 
Introduction 
Recent work in a variety of bacterial species has demonstrated that quorum 
sensing mechanisms can provide a means of intercellular communication and can 
facilitate cooperative transcriptional regulation of bacterial gene expression in a 
population (2, 7, 13). This orchestrated transcriptional regulation may allow for 
simultaneous expression of virulence factors, facilitating bacterial colonization or 
dissemination, and is important for the pathogenicity and adaptation of bacterial 
organisms.   
Campylobacter jejuni is an important enteric pathogen and has been demonstrated 
to produce autoinducer-2 (AI-2), a well know quorum sensing molecule resulting as a by 
product of s-adenosylmethionine (SAM) recycling (9). Previous publications have 
described multiple phenotypic changes in C. jejuni associated with mutagenesis of the 
luxS gene, including decreased motility, decreased autoagglutination, altered transcription 
of flagellar proteins and cytolethal distending toxin (5, 9, 14, 15, 24). Recent studies 
including our work demonstrated that LuxS contributes to Campylobacter colonization 
and pathogenecity in animal model systems  (Chapter 3 and reference 24). Several other 
enteric pathogens, including E. coli and Salmonella, have been demonstrated to respond 
to exogenous AI-2 with altered phenotypes including biofilm formation, motility, and 
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virulence (5, 10, 17, 29). In many cases these phenotypes are putatively associated with 
the bacteria’s ability to respond to changing environments and may be important to the 
colonization and pathogenicity of these organisms in the animal or human host.   
In C. jejuni very little information is currently available regarding the molecular 
mechanisms responsible for the previously observed luxS and AI-2 phenotypes nor the 
regulatory mechanisms responsible for their altered gene expression.  In order to better 
define the role of luxS and AI-2 in the metabolism and physiologic adaptation of C. 
jejuni, it is necessary to understand the global effect of the LuxS mutation or AI-2 on 
gene expression and phenotypes in this organism.   Hence the goal of this project was to 
perform a comprehensive evaluation of both phenotypic and transcriptomic changes 
associated with AI-2 mediated quorum sensing in C. jejuni.   
 
Materials and Methods 
Bacterial Strains and growth conditions 
Two C. jejuni strains were utilized in this study including W7 and W7∆luxS.  W7 
is a motile isolate of ATCC 700819 (also named NCTC 11168).  The luxS mutant has a 
kanamycin resistance cassette inserted into the luxS ORF and has been demonstrated to 
be phenotypically AI-2 negative (Chapter 2). 
The cultures were grown on Mueller-Hinton (MH) media and incubated at 42 °C 
in a microaerophilic chamber.  Cultures were stored at -80° C in MH media containing 
20% glycerol.  For transcriptomic and phenotypic microarrays the cultures were 
inoculated and grown simultaneously in the same microaerophilic chamber.  Growth was 
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monitored by measurement of OD600 and cultures with more than a 10% difference in 
OD600 following simultaneous incubation were excluded from the study.   
 
Microarray analysis of transcriptome 
(i) RNA Extraction and Preparation:  In the first microarray experiment six 
independent cultures of both the wildtype (W7) and mutant (W7∆luxS) strain were 
grown.  The paired samples were inoculated simultaneously at an OD600 of 0.05 and 
grown in a single microaerophilic chamber to an OD600 of 0.1.  Total RNA was collected 
as previously described (35).  For the second microarray experiment five replicates of the 
following bacterial growth were conducted.  A single culture of W7∆luxS was grown to 
an OD600 of 0.135.  This culture was split and 5 mL of culture were added to each of two 
bottles containing 20 mL of cell free supernatant from either W7 or W7∆luxS that had 
been grown to a similar OD600.  The bottles were gently agitated and allowed to grow at 
42 °C in a microaerophilic environment for 1.25 hours. After incubation the RNA was 
collected as above.  Briefly, the samples were treated with RNAProtect Bacterial reagent 
(Qiagen) and extracted using the RNEasy kit following the manufacture’s guidelines.  An 
on-column DNAase reaction was performed to provide additional assurance that there 
was no DNA contamination of the mRNA.  
RNA purification for the first microarray experiment from six replicates of paired 
growth W7 and W7∆luxS isolates yielded RNA concentrations between 324 – 755 
ng/µL.  Gel electrophoresis was performed on each sample to assure RNA integrity and 
purity.  Additionally the 260/230 ratio of the samples was measured and ranged from 
1.68-2.43 suggesting that contamination by guanidine was not a significant problem. For 
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the second microarray RNA purification from five replicates of paired growth yielded 
RNA concentrations between 423 – 871 ng/µL.  Gel electrophoresis was performed on 
each sample to assure RNA integrity and purity.  The 260/230 ratio of the samples ranged 
from 1.13-2.56. 
(ii) cDNA synthesis and hybridization: The procedure utilized was identical to 
that described by our previous paper (35).  The samples were processed using the 
Chipshot Indirect Labelling Kit (Promega) as recommended by the manufacturer.  For 
each sample 5 µg of RNA was used for cDNA synthesis.  Following a 4-hour incubation 
the resulting cDNA was eluted and labeled with either Cy-3 or Cy-5 dye.  For the 
samples of the first experiment, post labeling yields ranged from 2,046-3,192 ng of 
labeled cDNA with a fraction of incorporation ranging from 16.4-26.6%.  The total 
incorporation of dye ranged from 150-198 pmol per sample.  For the samples of the 
second experiment, post labeling yields ranged from 1,578-3,074 ng of labeled cDNA 
with a fraction of incorporation ranging from 15.7-26.7%.  The total incorporation of dye 
ranged from 120-216 pmol per sample.  Two-color microarray slides designed for C. 
jejuni and purchased from a commercial company (OciChip; Ocimum Biosolutions, 
Indianapolis, IN) were utilized in the experiment.  To control for dye-dependent bias on 
the slides we utilized a dye-swap design and normalized hybridization loading based on 
dye-incorporation (using 120-150 pmol of dye per sample) using the Nanodrop ND-1000 
(Nanodrop Technologies).  The Cy-3 and Cy-5 samples were mixed together, dried down 
using a vacuum evaporator and reconstituted in 150 µL of hybridization buffer supplied 
by the slide manufacturer.  The samples were incubated at 95 °C for 5 minutes, pulse 
centrifuged to collect any condensate and loaded onto the slides.  Slides were placed in a 
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hybridization chamber and incubated at 42 °C for 16 hours. All post-hybridization 
washes were performed as per the manufacturer’s recommendations.   
   
(iii) Data acquisition and analysis: Data collection and analysis were performed as 
described by Madsen et. al. (20) and modified by Yun et. al.  (35). Essentially the data 
was collected using a Scan Array Express (Applied Biosystems Inc, Foster City, CA) to 
determine the spot-specific mean signal strength and the spot-specific median 
background signal.  The mean spot signals were background subtracted, logged and 
median centered.   The median centered values were then subjected to a Lowess 
normalization process as previously described (34).   
 
Statistical analysis of the microarray data 
The normalized data was entered into an independent mixed linear model using 
SAS with fixed effects for treatment (wildtype versus luxS mutant) and dye.  Slide was 
entered into the model as a random effect.  A t-test was performed with the null 
hypothesis tested that the values between samples were the same.  Genes with a fold-
change greater the 1.25 and a p-value less then 0.05 were considered significant.  
 
Real-time PCR confirmation of genes with altered expression 
To validate the results of the microarray experiment select genes identified as 
differentially transcribed by the microarray were further evaluated for changes in 
transcription using real-time PCR as described previously (35). Each gene was tested in 
triplicate with three independent biological replicates. The gene expression was 
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normalized to that of the 16S rRNA gene for the given sample and the fold-change was 
calculated using the 2-∆∆CT method (19). The primer sequences used for amplification are 
presented in Table 1. 
 
Phenotypic microarray 
Phenotypic microarrays using both the wildtype and mutant strains were 
performed as described by the manufacturer with some modification.  (Biolog Inc, 
Hayward CA)  Briefly, the strains were grown on MH agar in a microaerophilic chamber 
for 18 hours.  They were harvested using sterile cotton swabs and transferred to tubes 
containing IF-1A or IF-10A media (Biolog. Inc, Hayward CA) to achieve a transmittance 
of 16%.  These cultures were then used to make the inoculating media as described by the 
manufacturer.  The inoculating media was added in 100 µL aliquots per well.  The plates 
were placed in a microaerophilic chamber.  Individual plates of the PM for each strain 
were inoculated sequentially and incubated in the same microaerophilic jars to assure 
similar growth times and conditions.  The plates were incubated at 42 °C for 24 hours and 
visually assessed using a subjective semi-quantitative scale (0 to +++).  Matching plates 
for each strain were evaluated side-by-side and digital photographs of each plate were 
taken.  After evaluation, the plates were returned to the microaerophilic chamber and 
incubated an additional 24 hours and the evaluation process was repeated.   
 
Patulin Sensitivity Testing 
Commercially purified patulin was obtained from A.G. Scientific.  A 10 mg/mL 
stock solution of patulin was made in DMSO.  This stock solution was then used to make 
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a 512 µg/mL starting solution for serial dilution.  100 µL of this solution was added to the 
first well of a microtiter plate and a 2-fold serial dilution was performed in the same 
manner used for standard MIC testing.  An equal volume of bacterial cells containing 
approximately 1 x 104 cells/mL were added to each well and incubated in a 
microaerophilic chamber at 42° C for 72 hours.  At 72 hours the plates were removed and 
evaluated for bacterial cell growth observed as a cell pellet in the bottom of the well. 
 
Results 
Microarray 
Two independent microarray experiments were conducted in this study.  In the 
first experiment, the cDNA from the W7 and W7∆luxS strains were competitively 
hybridized to assess the transcriptomic changes associated with the mutagenesis of the 
luxS gene.  In the second set of experiments the W7∆luxS strain was grown in the 
presence of 80% cell free supernatant containing AI-2 (cell free supernatent from W7) or 
not containing AI-2 (cell free supernatent from W7∆luxS).  This experiment was 
designed to assess the transcriptomic changes associated with the presence of AI-2 in the 
media.  
 In the first microarray experiment, a total of 35 genes were identified that met the 
requirements of having at least a 1.25-fold change and having a p-value less then 0.05.  
The genes with altered expression are listed in Table 1.  Of these genes 20 were up-
regulated and 15 were down-regulated, collectively representing roughly 2% of the 
genome with altered transcriptional expression.  The gene with the greatest fold change in 
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expression was Cj1198, the luxS gene.  This ORF had been mutated by insertional 
mutation to generate the W7∆luxS strain and would be expected to have a significant 
change in transcription.  This finding also provides a good validation of the hybridization 
and scanning methodology.  There were 5 genes identified that were related to genetic 
information processing and/or protein translation.  Included in this group were two 
elongation factors (Cj0460 and Cj1379), a t-RNA synthetase (Cj0765c) and a ribosomal 
protein (Cj1072).  The largest functional category identified was the group associated 
with environmental information processing and membrane transport, which included 9 
genes.  Some of these genes have putative roles as two-component sensor kinase systems 
(Cj1226c), ABC transporters (Cj1180c and Cj0142c), and permeases or ion channel 
proteins (Cj0941c and Cj0238).  Four genes were found to be involved in cellular 
metabolism (Cj1198, Cj1106, Cj0145 and Cj1509c) and two genes, both of which were 
upregulated, were found to be involved in lipoprotein or phospholipid synthesis (Cj0329c 
and Cj0341c).  The remaining genes were identified in the hypothetical protein (7 genes) 
or miscellaneous protein (8 genes) categories.   
 To confirm the findings of the first microarray experiment, real-time PCR was 
performed on 6 of the genes with altered transcription.  Of these 6 genes, 3 were found to 
have a similar trend in expression based on real-time PCR and three were found to have 
the opposite trend.  Given that these genes showed fairly low fold changes on the 
microarray it is likely that the ones with disparate results were false positives identified 
by the microarray.    
 In the second microarray experiment we utilized an approach designed to test for 
transcriptional changes associated with the presence of AI-2 in the culture media.  For 
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this experiment, identical cultures of W7∆luxS were grown in media containing 80% cell 
free supernatant from either W7 (includes endogenous AI-2) or W7∆luxS (no AI-2).   
Thirty genes were identified as having altered expression using the microarray and a cut-
off of a p-value less than 0.05 and a fold change equal or greater then 1.5 fold.  Of the 
thirty genes, 17 were up-regulated in the absence of AI-2 and 13 were down-regulated in 
the absence of AI-2, again suggesting that roughly 2% of the genome was differentially 
transcribed.  Of these genes six were evaluated by real-time PCR and the general trend in 
regulation was confirmed in two.  Two of the genes were found to be associated with 
genetic information processing (Cj0670 and Cj0586), one of which is the rpoN sigma-54 
factor of C. jejuni that has previously been shown to regulate transcription of flagellar 
proteins.  The environmental information processing and membrane transport category 
contained 5 genes with similar function to those identified in the first microarray, 
including a couple of two component sensor kinase systems (Cj0643
 
and Cj0890), genes 
associated with membrane transport (Cj1583c and Cj0180) and a single gene listed as a 
putative integral membrane protein (Cj0167c).  There were eight genes with functions 
related to a wide variety of cellular metabolic processes.  Interestingly, two of these genes 
(Cj1378 and Cj1504c) function along with one of the proteins identified in the first 
microarray (Cj1379) in the formation of selenocysteine and selenoproteins.  The 
remainder of the identified genes were categorized as hypothetical proteins (5 genes) and 
miscellaneous proteins (10 genes).  The miscellaneous protein group included genes with 
many diverse functions but does include two genes with function related to SAM, the 
metabolic cycle in which luxS functions.  A putative methyl transferase (Cj0495) was  2 
fold up-regulated in the presence of AI-2 and a radical SAM domain protein (Cj1244) 
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was 1.9 fold down-regulated in the absence of AI-2.  The remainder of the miscellaneous 
genes did not appear to share a consistent link in function. 
 
Phenotypic Microarray 
The results of the phenotypic microarray demonstrated limited phenotypic 
changes associated with the mutagenesis of the luxS gene.  No significant changes in 
carbon source utilization or viability were detected.  There was a slight trend towards 
improved growth of the luxS mutant strain in various osmolyte-containing solutions at the 
24-hour time point, however it was subtle and not possible to quantify beyond visual 
observation.  Furthermore, at the 48 hour read the plates looked identical.  No additional 
changes were observed at the 48 hour read compared to the 24 hour beyond the 
differences on the plate testing for osmolytes.  Table 3 shows the results of the other 
changes observed in the phenotypic microarray.  The majority of these changes are 
associated with a change observed in a single well of the four well dilution series.  While 
the exact concentration of the compounds contained in each well is proprietary 
information and not shared by the company, the wells represent a 2 fold dilution series.  
Thus compounds that show a single well variation possibly are within the standard 
deviation of the test.  For that reason we decided to concentrate our efforts on compounds 
with differences in multiple wells which left three compounds of interest: 5,7-Dichloro-8-
hydroxyquinaldine, patulin and tolylfluanid.  For tolylfluanid and 5,7-Dichloro-8-
hydroxyquinaldine, no immediate significance of these compounds in the environment or 
physiology of bacteria could be identified and they have not been further pursued at the 
present time.  In contrast, patulin was identified as secondary toxic metabolite of fungal 
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growth that is capable of covalently binding to sulfhydryl groups on proteins and 
glutathione (21).  Given the role of luxS in the metabolic recycling of methionine and 
homocysteine an association of an altered phenotype to a compound known to bind to 
sulfhydryl groups seemed plausible.  To confirm the findings of the phenotypic 
microarray both W7 and W7∆luxS were grown in MH media containing a 2 fold serial 
dilution of patulin.  W7 demonstrated a MIC of 0.25 µg/mL while the W7∆luxS strain 
showed a 2-fold higher MIC of 0.5 µg/mL.  These results suggest that luxS mutant strains 
have a decreased sensitivity to the toxic effects of patulin.   
 The PM also allows us to systematically evaluate C. jejuni carbon source 
utilization and growth in various physiologic conditions.  The results outlined in figure 1 
are carbon sources that were utilized by both the W7 and the W7∆luxS strains.  The 
results demonstrate that no hexameric sugar compounds are effectively utilized by C. 
jejuni and further demonstrate that both Serine and Glutamate were well utilized.  These 
finding are consistent with a large body of evidence suggesting that C. jejuni 
preferentially utilizes amino acids as the primary carbon source.  The PM also tests for 
growth in varying pH ranges and demonstrated that both strains grew well between a pH 
between 4.5 and 10.  Again, these results are consistent with previous work that has 
demonstrated that C. jejuni does not grow at a pH below 4.5 (22, 23). 
 
Discussion 
 The results of the two microarray studies detailed in this chapter suggest that luxS 
and AI-2 play limited roles in the regulation of gene expression of C. jejuni in the growth 
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media and conditions used in this study.  For each experiment there was differential 
transcription of roughly 2% of the genome, which is in contrast to similar microarray 
experiments in E. coli where 5-10% of the genes were differentially expressed and there 
was evidence for luxS acting as a global regulator (8, 29).  Given that MH media and the 
microaerophilic chambers utilized for culture in this study provide a relatively favorable, 
consistent and nutrient rich environment we cannot rule out the possibility that more 
significant transcriptional regulation changes would be observed in the more hostile 
conditions associated with environmental or in vivo growth.    
 In the conditions tested several genes of particular interest were identified and 
verified with real-time PCR as being differentially regulated.  Notably, the gene with the 
highest fold-change difference in the first microarray was the Cj1198 gene, which is the 
luxS ORF and was roughly 10 fold down regulated in the W7∆luxS.  While the exact 
sequence of the oligo primers used on the commercial microarray utilized in the 
experiment are proprietary information, this change would suggest that the probe 
hybridizes in a region that is disrupted by the insertional mutagenesis of the ORF.  
Regardless, the identification of this gene as being the most highly down-regulated gene 
helps to validate the protocol and the microarray platform.   
The first microarray experiment also identified a putative two-component sensor 
kinase, Cj1226c, as being differentially regulated with a roughly 1.5 fold increase in 
expression in the W7∆luxS strain.  This finding was confirmed by real-time PCR which 
demonstrated a slightly larger fold change at 2.5 fold.  Other bacterial species such as 
Vibrio harveyi have been demonstrated to utilize two-component sensor kinases as a 
mechanism of signal transduction associated with quorum sensing, however most enteric 
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organisms that have been studied utilize an ABC transporter to internalize AI-2.  At the 
present time there is no evidence to support that either of these mechanisms is functional 
in C. jejuni.  A recent publication has defined the role of Cj1226c along with its cognate 
response regulator Cj1227c and named them CprSR for Campylobacter planktonic 
growth regulation (31).  Mutagenesis of the cprsS gene resulted in an increased biofilm 
formation, a dose-dependent colonization defect in chickens, slightly enhanced 
intracellular survival and poor growth in high osmotic conditions (32). Proteomic 
analysis of the cprsS mutant demonstrated that the luxS was significantly downregulated 
in the mutant as compared to the wildtype.  Given our identification of altered 
transcription of this gene associated with luxS mutagenesis, we believe that there is the 
potential for a feed-back loop regulator system between this two-component signaling 
system and luxS, however additional work will be necessary to confirm such a 
hypothesis.  Furthermore, the described role of Cj1226c in the osmotic stress response 
may in part account for the differences observed in osmotic growth on the PM. 
 Cj0824 was upregulated 1.6 fold in the W7∆luxS strain but was not tested by real-
time PCR.  This gene is an undecaprenyl diphosphate synthase that is responsible for the 
formation of undecaprenyl pyrophosphate, a lipid carrier for bacterial peptidoglycan 
biosynthesis (4).  At this time, the significance of this gene is Campylobacter 
peptidoglycan synthesis is completely unknown and warrants further evaluation.  This 
gene, along with transcriptional changes observed in Cj1305c (a hypothetical protein 
located in an O-linked glycosolation lucus), Cj0941c (a putative permease), Cj0553 
(putative integral membrane protein), Cj0609c (possible periplasmic protein), Cj0341c 
(putative integral membrane protein), Cj0238 (putative mechanosensitive ion channel 
102 
family protein), Cj0633 (putative periplasmic protein), Cj1106 (putative periplasmic 
thioredoxin), Cj1626c (putative periplasmic protein) and Cj0486 (putative sugar 
transporter) may suggest a significant role of luxS in the normal physiology of the 
bacterial cell membrane and periplasmic space.  Further evidence for a role of luxS or AI-
2 mediated quorum sensing in membrane structure is provided by the identification of the 
plsX (Cj0329c) in the first microarray and the plsC (Cj0516) gene in the second 
microarray.  These two genes have been demonstrated to play critical roles in bacterial 
membrane glycerophospholipid synthesis.  Specifically, plsX is an acyl-ACP:phosphate 
transacylase that generates acyl-phosphate which acts as a acyl donor in an essential step 
of the formation of phosphatidic acid (36). There is evidence that regulation of the plsX 
gene may be the essential step for coordination of the fatty acid and phospholipid 
synthesis by many bacteria (36).  The plsC gene also plays an important role in this 
process as the enzyme that catalyzes the final acylation of 1-acylglycerol-phosphate to 
phosphatidic acid (36).  Taken together there appears to be a significant association of 
luxS and AI-2 with genes important for the maintenance and development of the bacterial 
cell membrane and the periplasmic space.  Such changes would certainly be important in 
responding to different environmental conditions and perhaps in the development of 
biofilms which have been reported in C. jejuni and are linked to quorum-sensing 
mechanisms in other bacterial species (1, 3, 6, 31). 
 There appears to also be a role of luxS or AI-2 in mediating phosphorous uptake 
and utilization in C. jejuni as both microarray experiments identified a gene associated 
with phosphate utilization.  The first microarray showed a 1.6-fold down regulation of the 
Cj0613 gene, a putative periplasmic phosphate binding protein associated with the uptake 
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of phosphate from the environment.  Previous work on this gene has demonstrated that it 
is under the control of the Pho regulon, which is controlled by the PhosS/PhosR (Cj0889-
890) two component signal transduction system (33). Interestingly, the PhosR response 
regulator (Cj0890) was identified by the second microarray as being 2 fold up-regulated 
in the absence of AI-2 and real-time PCR on that gene confirmed the up regulation with a 
3-fold change. While it is presently unclear what association there is between 
phosphorous metabolism and luxS or AI-2, it is clear that adequate phosphorous uptake is 
necessary for cellular viability and survival in harsh environments like that encountered 
by C. jejuni.  One could hypothesize that sensing of high levels of bacterial signal 
compounds could “signal” to other organisms in the environment the competitive need 
for nutrients and induce an increased uptake of necessary nutrients. 
 Selenium is an important micronutrient necessary for the growth of many 
bacteria.  Increasing interest in the utilization of this metal has demonstrated its 
importance in the formation of selenocysteine that is co-translationally inserted into 
proteins yielding selenoproteins or selenoenzymes (30).  Additionally selenium has been 
demonstrated to serve as an electron acceptor in some anaerobic systems and as a 
cofactor in selenium methyltransferases (30).  Selenocysteine is often referred to as the 
21st amino acid and utilizes a UGA codon associated with a downstream selenocysteine 
insertion sequence (SECIS) that forms a stem-loop structure in the mRNA (30).  This 
process requires four essential genes: SelA which is a selenocysteine synthase, SelB 
which is a special translation factor that recognizes selenocystsl-tRNASec, SelC which is a 
Sec-specific tRNA (tRNASec) and finally SelD which is a selenophosphate synthase.  
Surprisingly, between the two microarray experiments three of these four genes were 
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independently identified as differing in their transcriptional rates.  The first experiment 
showed a 2 fold down regulation of selB (Cj1379) in the W7∆luxS strain compared to the 
wildtype W7 strain.  The decrease in transcription of the gene in the absence of AI-2 is 
consistent with the results of the second microarray that showed a roughly 1.65-fold 
upregulation of both the selA (Cj1378) and selD (Cj1504c) genes when AI-2 was present 
compared to its absence. Given that two of the genes are only identified in the microarray 
where AI-2 is present or absent suggest that AI-2 may be directly involved in this 
response, although we cannot rule out a possibility that the change is seen in response to 
increased s-ribosylhomocysteine (SRH) levels present in the spent media of W7∆luxS.  
One possible explanation is that the altered levels of SRH result in changes associated 
with cysteine metabolism and thus alter selenocysteine formation.  Alternatively, it is 
possible that these results are associated with an indirect regulation of the genes exerted 
through an unknown regulator pathway yet to be resolved.   
 In addition to the ones listed above four other genes of particular interest were 
identified by the second microarray experiment.  These genes are of interest based on 
their potential to either serve to control transcriptional regulation or as a result of their 
link to luxS.  The first of these genes is Cj0670, the rpoN RNA polymerase factor sigma-
54 that is associated with global regulation of flagellar activity (16).  Cj0670 was roughly 
3.5 fold up regulated in the presence of AI-2 based on microarray and that result was 
confirmed with real-time PCR demonstrating a upregulation of 1.9 fold.  Upregulation of 
sigma 54 would result in increased flagellar biosynthesis and thus the potential for 
increased motility, a phenotype observed in AI-2 competent cells when compared to luxS 
mutant strains.  Given the global regulator nature of sigma-54 and its role in motility the 
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regulation of Cj0670 warrants further study as a possible mechanism of explaining the 
most consistent phenotype observed in C. jejuni luxS mutants, i.e. altered motility.  A 
two-component response regulator was also identified as being differentially expressed in 
the presence of AI-2.  Cj0643, the cbrR, gene was 2 fold down regulated in the presence 
of AI-2.  This gene has been associated with resistance to bile salts, a key ability for 
colonization of the preferred habitat of C. jejuni in the gastrointestinal tract of birds and 
mammals (25). The third gene of interest is the Cj1244 gene that was roughly 2-fold 
down regulated in the presence of AI-2.  This gene is a putative radical SAM domain 
protein.  This family of proteins includes upwards of 2800 enzymes that utilize s-
adenosylhomocysteine (SAM) and iron-sulfur clusters contained on the active site of the 
protein to catalyze radical-mediated reactions.  The W7∆luxS strain utilized in this study 
would be expected to have altered SAM recycling associated with the mutagenesis of the 
luxS gene, however the interesting point is that the transcription of this SAM radical 
protein is differentially expressed in the presence of AI-2.  We were also surprised to see 
an altered transcription of the Cj0495 gene, which encodes a putative methyltransferase 
gene that was 2-fold upregulated in the presence of AI-2.  The identification of such a 
change by the first microarray would have been less surprising given the loss of luxS 
function and SAM recycling, but to see this change simply as the result of the difference 
in growth media was not expected.  The changes in these last two genes would suggest 
that regulation of these genes is not simply associated with the loss of luxS activity but is 
actually a response to the differences in culture free supernatant and could represent 
potential sensing of AI-2 or a mechanism of chemotaxis. 
106 
 Recently the results of a cDNA microarray performed on C. jejuni wildtype and 
luxS mutant in the presence or absence of H2O2 were reported (11). The list of genes 
identified does not overlap significantly with those identified in this current study, 
however there were significant differences associated with the conditions of the 
experiment and the C. jejuni strain utilized for the experiment.  One distinct difference 
that should be noted was the use of a non-commercial microarray slide that was different 
from the commercial version used in this study.  In general similar functional catagories 
(ie. ABC transporters, flagellar proteins and motility) were found to be differentially 
expressed but the specific gene products were not the same.  Another recent publication 
failed to identify significant transcriptional changes associated with the addition of 
exogenous AI-2 to mid-exopnential growth cultures of both wildtype and luxS mutant C. 
jejuni  (12).  These findings are consistent with the identification of a minimal number of 
genes with modest fold-change as described in this current report. 
The most noticeable change identified by the phenotypic microarray was a three 
well difference in the sensitivity to patulin with the wildtype strain being more sensitive.  
Patulin is a secondary toxic metabolite produced by several species of fungi including 
Penicillium and Aspergillus.  It has been demonstrated to negatively affect rumen 
function in cattle as a result of feeding forages that contain high levels of patulin 
secondary to fungal contamination (21).  Furthermore, patulin is a recognized mycotoxin 
of fruit based foods and beverages including apple juice and is an important food safety 
concern in human infants (27).  It has been previously demonstrated that patulin readily 
binds to sulfhydryl groups and that this covalent binding is responsible for both its toxic 
effects on eukaryotic cells as well as its neutralization by sulfhydryl containing 
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compounds  (18, 27, 28).  We hypothesize that the decreased sensitivity of the W7∆luxS 
strain is a result of increased concentrations of s-ribosylhomocysteine (SRH) observed in 
luxS mutant strains (Chapter 2). Since luxS mutants are unable to convert SRH to 
homocysteine and DPD there is a significant increase in the concentration of this 
metabolite in the extracellular media.  This would result in the presence of sufficient 
sulfhydryl groups to act as a neutralization mechanism and decrease the cellular toxicity 
to the bacteria.  Interestingly, patulin has recently been identified as an inhibitor of the 
quorum-sensing system of Pseudomonas aeruginosa (26). In that study they 
demonstrated a direct acceleration of the LuxR regulator in the presence of patulin.  It is 
important to realize that C. jejuni utilizes a different quorum-sensing system from that 
described for P. aeruginosa and does not contain a LuxR homolog.  Therefore, it seems 
unlikely that the difference observed in the patulin senstitivity phenotype utilizes a 
similar mechanism to that described in Pseudomonas.   
We were surprised at the limited phenotypic changes associated with mutagenesis 
of a gene that has significant metabolic functions and putative quorum-sensing roles.  
Several issues associated with the phenotypic microarray could have contributed to this 
lack of significant differences.  The phenotypic microarray (PM) plates were originally 
designed for use with common enteric pathogens (ie. E. coli and Salmonella spp.) and 
consequently the concentrations of nutrients and toxins have been optimized for these 
organisms.  When the PM assay is utilized for other pathogens, like C. jejuni, the 
concentrations of these test reagents remain the same and the plates are simply incubated 
in an appropriate culture temperature and atmosphere.  This results in a situation where 
the test reagent concentrations are not optimized in every well for the specific bacteria 
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being tested and possibly a significant loss of data due to concentrations above or below 
the apparent MIC of the organism.   A second issue associated with our use of the PM 
array for C. jejuni is the lack of kinetic data due to the requirement for microaerophilic 
conditions of the organism and the lack of access to the equipment to monitor the 
kinetics.  Since the colorimetric change monitored in the PM array is a redox reactions 
associated with cellular respiration, it is possible that monitoring the color change every 
24 hours led to the loss of some significant differences that might have been identified 
using a continuous monitoring method.  Furthermore, although we attempted to utilize 
spectrophotometric measurement of all the wells as a quantitative assessment we were 
unable to do this in an efficient manor given the number of plates that needed to be read.  
Hence, the results presented herein were derived from visual observation and comparison 
of the plates by the naked eye and the use of a subjective semi-quantitative scoring 
system (- to +++).   
 Collectively the results presented here suggest that luxS and AI-2 are involved in 
the transcriptional regulation of a limited number of genes in Campylobacter.  However, 
the altered expression of a sigma factor, multiple two-component sensor systems, and 
genes involved in phosphorous utilization, selenium utilization and cell wall synthesis 
suggest that LuxS and AI-2 contributes to Campylobacter adaptation to various 
environments.  Additional work on these specific mechanisms will improve our 
understanding of how C. jejuni responds to environmental conditions including the in-
host niches.  Finally, it is also important to realize that the growth media used in this 
study was very different from the conditions encountered in the in vivo environment of 
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the gastrointestinal system, and thus we cannot rule out a more significant role of luxS in 
those harsh environments. 
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Figure Legends 
 
Figure 1: 
 
Carbon source utilization of C. jejuni based on the phenotypic microarray 
The phenotypic microarray demonstrated that both W7 and W7∆luxS effectively utilized 
the same carbon sources.  This figure shows the test results obtained.  Each positive well 
is identified with a sequential number placed above the well that corresponds to the well 
label provided in the table below. 
 
Figure 1 
 
Carbon Source 
Succinic Acid  
L-Aspartic Acid  
L-Proline  
L-Lactic Acid  
Formic Acid  
L-Glutamic Acid  
D,L Malic Acid  
D-Ribose  
L-Asparagine  
α-keto-Glutaric Acid  
L-Glutamine  
α hydroxy Butyric acid  
Citric Acid  
Fumaric Acid  
Bromo succinic acid  
L-Serine  
Methyl Pyruvate  
D-Malic Acid  
L-Malic Acid  
L-Lyxose  
Pyruvic acid  
D-Arabinose  
2-deoxy-D-ribose  
5-keto-D-gluconic acid  
D-lactic acid methyl ester 
Oxalomalic acid  
Dihydroxyacetone 
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Well Label
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13 
14 
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16 
17 
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20 
21 
22 
23 
24 
25 
26 
27 
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Tables 
Table 1: Primers for real-time PCR 
Cj0329cF1 GGAAATGCCACAGATGCTTT 
Cj0329cR1 CCACTATGACCCGCTGAAAC 
Cj0413F1 AAGCTTGCACTTTAGGAGAATCA 
Cj0413R1 TGAGGCCATTTGTCCATCTT 
Cj0495F1 TCTCACAAGGCGATTTTGAA 
Cj0495R1 GCTTTGTACATACACATCAAAGCA 
Cj0741F1 AAACAAGGGGGTGAAGATCC 
Cj0741R1 TGCGTCTACTTCGGTTTGAA 
Cj0889cF3 TTTCACGTCAAAGCGTTAAACT 
Cj0889cR3 GCATCTGCAAGGCTTCACTA 
Cj0890cF1 AGAAATTTGCCCAGTGGAGA 
Cj0890cR1 AAGCCTTGGCTGTAAGAAAAA 
Cj1068F1 GCGTGAATTTAAAGGCACAAA 
Cj1068R1 CAAAACCAGGACGCATATCA 
Cj1180cF2 GGACAACAACAGCGTGTGA 
Cj1180cR2 TTTCCAGTTGCTTCATCAGC 
Cj1198F1 AAGCGTAAGCGATCAAAGCA 
Cj1198R1 GGCAATTTGTTTGGTTCAT 
Cj1226cF1 AGAGCGCTTAAATGGGGTTT 
Cj1226cR1 GCAGCCCCTGAAGTAATTTG 
Cj1322F1 AAAGCAAGCTCAATATATACGAA 
Cj1322R1 CCGGCGTTAAAATTAGAAAA 
Cj1471cF2 GCCTTTGATTTATGGCGAAA 
Cj1471cR2 TTCCATTGGGACGATGTAAAA 
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Table 2: Fold change data for W7∆luxS /W7 
Gene Function P value Microarray 
fold change  
Real-time 
fold change 
Genetic Information Processing, Transcription 
Cj0460 nusA transcription elongation 
factor 
0.0017 1.347 ND 
Cj0471 rpmG 50S ribosomal protein L33 0.0125 1.41 ND 
Cj0765c hisS histidyl-tRNA synthetase 0.026 0.793 ND 
Cj1072 rpsR 30S ribosomal protein S18 0.027 0.757 ND 
Cj1379 selB putative selenocysteine-
specific elongation factor 
0.0414 0.583 ND 
Environmental Information Processing, Membrane Transport 
Cj0142c putative ABC transporter ATP-
binding protein 
0.0432 1.424 ND 
Cj0238 putative mechanosensitive ion 
channel family protein 
0.0285 0.674 ND 
Cj0486 putative sugar transporter 0.0468 0.720 ND 
Cj0553 putative integral membrane protein 0.0141 0.748 ND 
Cj0613 pstS putative periplasmic 
phosphate binding protein 
0.0292 0.660 ND 
Cj0941c putative permease 0.012 1.396 ND 
Cj1180c putative ABC transporter ATP-
binding protein 
0.0065 1.396 0.217 
Cj1226c putative two-component sensor 
(histidine kinase) 
0.0117 1.577 2.5 
Cj1471c ctsE putative type II protein 
secretion system E protein 
0.0063 1.302 0.5 
Metabolism 
Cj0145 putative TAT (Twin-Arginine 
Translocation) pathway signal 
sequence domain protein 
0.0477 0.772 ND 
Cj1106 putative periplasmic thioredoxin 0.0426 1.489 ND 
Cj1198 luxS 0.006 0.093 0.008 
Cj1509c fdhC putative formate 
dehydrogenase, cytochrom B 
subunit 
0.0491 1.285 ND 
Hypothetical Proteins 
Cj0044c Hypothetical protein 0.0187 0.770 ND 
Cj0364 Hypothetical protein 0.0003 0.675 ND 
Cj0741 Hypothetical protein 0.0149 1.508 0.685 
Cj0877c hypothetical protein 0.0249 1.947 ND 
Cj1305c Hypothetical protein, located in O 
linked glycosolation locus  
0.0001 0.495 ND 
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Cj0569 hypothetical protein 0.0341 1.438 ND 
Cj1465 hypothetical protein, flagellar 
locus 
0.0387 1.258 ND 
Phospholipid synthesis and lipoproteins 
Cj0329c plsX putative glycerol-3-phosphate 
acyltransferase 
0.0345 1.516 1.36 
Cj0341c putative integral membrane protein 0.0234 1.355 ND 
Miscellaneous, periplasmic 
Cj0499 putative histidine triad (HIT) 
family protein 
0.0201 1.414 ND 
Cj0556 putative amidohydrolase family 
protein 
0.0299 0.726 ND 
Cj0609c possible periplasmic protein 0.0198 0.766 ND 
Cj0633 putative periplasmic protein 0.032 1.382 ND 
Cj0800c putative ATPase 0.0421 1.404 ND 
Cj0824 uppS undecaprenyl diphosphate 
synthase  
0.0226 1.657 ND 
Cj1066 rdxA nitroreductase 0.0407 0.773 ND 
Cj1626c putative periplasmic protein 0.0466 1.295 ND 
ND = Not Determined 
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Table 3: Fold Change data for AI-2 present/ AI-2 absent 
Gene Function P value Microarray 
fold change 
Real-time 
fold change 
Genetic Information Processing, Transcription 
Cj0586 ligA NAD-dependent DNA ligase 0.0300 1.50 ND 
Cj0670 rpoN RNA polymerase factor 
sigma-54 
0.0096 3.57 1.9 
Environmental Information Processing, Membrane Transport 
Cj0167c putative integral membrane protein 0.0377 2.35 ND 
Cj0180 exbD1 biopolymer transport 
protein, part of outer membrane 
energy transducing system 
0.0043 1.72 ND 
Cj0643 cbrR two-component response 
regulator 
0.0019 0.533 * 
Cj0890 putative sensory transduction 
transcriptional regulator  
0.0395 0.51 0.333 
Cj1583c putative peptide ABC-transport 
system permease protein 
0.0111 1.69 ND 
Metabolism 
Cj0004 monohaem cytochrome C 0.0448 3.59 ND 
Cj0130 tyrA prephenate dehydrogenase 0.0111 0.577 ND 
Cj0348 trpB tryptophan synthase subunit 
beta 
0.4334 0.65 ND 
Cj0516 plsC putative 1-acyl-SN-glycerol-
3-phosphate acyltransferase 
0.0414 2.00 ND 
Cj0345 trpE putative anthranilate synthase 
component I 
0.0386 0.59 ND 
Cj1378 selA selenocysteine synthase 0.0003 1.661 ND 
Cj1504c selD putative selenide,water 
dikinase 
0.0351 1.76 ND 
Cj1652c murI glutamate racemase 0.0271 0.64 ND 
Hypothetical Proteins 
Cj0916c conserved hypothetical protein 0.0401 0.64 ND 
Cj0970 hypothetical protein  0.0242 1.55 ND 
Cj0974 hypothetical protein 0.0082 0.53 ND 
Cj1069 conserved hypothetical protein 0.0393 1.52 ND 
Cj1322 hypothetical protein, located in O 
linked glycosolation locus  
0.0231 2.37 0.5 
Miscellaneous, periplasmic 
Cj0121 putative metalloprotease 0.0340 0.52 ND 
Cj0353c phosphatase 0.0414 0.62 ND 
Cj0413 putative periplasmic protein 0.0006 3.21 0.833 
Cj0495 putative methyltransferase domain 0.0127 2.07 0.66 
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protein 
Cj1068 putative peptidase M50 family 
protein 
0.0014 2.00 0.5 
Cj1244 putative radical SAM domain 
protein 
0.0307 0.54 ND 
Cj1275c putative peptidase M23 family 
protein 
0.0251 0.607 ND 
Cj1404 nadD putative nicotinate-
nucleotide adenylyltransferase 
0.0111 1.57 ND 
Cj1521c putative CRISPR-associated 
protein 
0.0233 0.617 ND 
Cj1715 putative acetyltransferase 0.0273 2.06 ND 
ND = Not Determined 
* Unable to get reliable real-time PCR data 
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Table 4: Phenotypic microarray results 
PM 
Plate 
Test Substance W7 W7∆luxS 
4 Phosphonoacetic acid 
 
 
13 2,2’ Dipyridyl 
  
13 5-flourouracil 
  
15 Guanidine Hydrochloride 
 
 
15 5,7-Dichloro-8-
hydroxyquinaldine 
 
 
16 1-chloro-2,4 dinitrobenzene 
  
17 Phenylarsine oxide 
  
18 Pentachlorophenol 
  
18 Na Bromate 
  
18 Antimony III Chloride 
  
19 Cinnamic acid 
  
19 Hexochlorophene 
  
20 Pridinol 
  
20 Patulin 
  
20 Tolylfluanid 
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Chapter 5: Summary 
 As a leading cause of foodborne illness, C. jejuni encounters constantly changing 
environments and niches during transmission, colonization and growth. The broad 
sources of human Campylobacter infections ranging from processed meat to ground 
water provides evidence of the ability of this organism to adapt to and survive in highly 
divergent environmental conditions.  Its adaptability is even more remarkable when one 
considers the microaerophilic nature of Campylobacter and its survival in sites that 
appear to be exposed to normal atmospheric levels of oxygen.  It is this high degree of 
adaptability and versatility that has allowed C. jejuni to become almost ubiquitous in its 
distribution and highly efficient in transmission (7).  A better understanding of the 
molecular and cellular mechanisms responsible for adaptation to diverse environments 
and hosts will provide new insights into both the mechanisms of disease and potential 
targets for intervention.  
 Quorum sensing has been demonstrated to be an important component of 
environmental adaptation of several bacterial organisms and the identification of a LuxS 
mediated quorum sensing system in C. jejuni has resulted in the publication of several 
papers relating to its role in limited number of phenotypes (1-6, 8).  Despite these reports, 
there continues to be significant knowledge gaps in our understanding of the role of luxS 
and AI-2 in environmental adaptation as well as the molecular pathways responsible for 
this response.  Research from this thesis provides new insights into several key roles of 
the luxS enzyme and AI-2 in the pathobiology of C. jejuni .   
  Firstly, we provide direct evidence of a critical role for the G92 amino acid in the 
enzymatic activity of the C. jejuni LuxS enzyme.  The identification of a naturally 
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occurring AI-2 deficient strain harboring a G92D mutation provides evidence of the key 
function of a single amino acid in the production of AI-2.  Furthermore, the highly 
conserved nature of this amino acid across a large range of bacterial luxS genes from both 
gram positive and gram negative organisms suggest that it may play an equally important 
role in other bacterial species.  This study also provided insight into the metabolic role of 
LuxS in the normal physiology of Campylobacter and demonstrated that mutagenesis 
(experimental or naturally occurring) of luxS results in the extracellular accumulation of 
S-ribosyl homocysteine as a result of altered SAM recycling.  Consequently, the 
evaluation of phenotypic changes associated with the loss of a fully functional luxS gene 
must be interpreted with both quorum sensing and metabolism in mind. 
 Secondly, we examined the physiologic role of luxS and AI-2 in the competitive 
fitness and virulence of C. jejuni.  We provide strong evidence for a role of luxS and or 
AI-2 in ensuring fitness of C. jejuni in the chicken intestinal environment, the primary 
site of Campylobacter colonization in animal reservoirs.  Inoculated alone it appears that 
both wildtype and luxS mutant strains are able to colonize to high levels for a sustained 
period of time in the chicken.  In contrast, when equal numbers of wildtype and luxS 
mutant strains are simultaneously co-inoculated into chickens, the luxS-deficient strain is 
outcompeted by the wildtype strain and in some cases is completely excluded by the 
wildtype.  This finding is significant in better understanding how various strains of C. 
jejuni with differing AI-2 phenotypes (as demonstrated in the previous chapter) are able 
to compete to colonize the ecological niches in vertebrate hosts.  We also demonstrate 
that a functional luxS enzyme is absolutely required for the effective pathogenesis of C. 
jejuni abortions in the pregnant guinea pig model.  Experimental mutagenesis of luxS in a 
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highly virulent abortifacient strain resulted in complete ablation of fetal/placental 
infections and abortions following oral inoculation and this defect could be fully restored 
by genetic complementation with an intact luxS ORF.  Interestingly, this abortion 
potential of the luxS mutant strain was also restored when the strain was administered 
directly into the peritoneal cavity where it rapidly became systemically disseminated.  
This difference in phenotype associated with route of administration helps to localize the 
pathogenesis defect to the level of intestinal colonization or bacterial translocation across 
the intestinal mucosa, both of which rely heavily on environmental adaptation to new 
energy substrates, immune cell evasion and competition with other commensal bacteria.  
Future work focused on the molecular mechanisms responsible for this defect may 
provide important clues for treatment and control of human intestinal colonization and 
dissemination by this pathogenic organism. 
 Thirdly we utilize both transcriptomics and phenotypic microarrays to further 
elucidate potential mechanisms responsible for the differences observed in the previous 
chapter.  The results of the cDNA microarray studies demonstrate that both luxS 
mutagenesis and altered extracellular AI-2 concentrations can result in differential 
expression of genes important for a variety of environmental adaptive processes.  
Evidence exists for a role of these genes in the response to altered phosphorous 
concentrations (a situation commonly encountered in the host intestinal tract), selenium 
metabolism, phospholipid biosynthesis and environmental and genetic information 
processing.  Additionally, the identification of the altered transcription of rpoN (sigma-54 
factor) that has been associated with regulating many flagellar structural and regulatory 
proteins is consistent with the phenotypic changes observed by previously published 
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studies that demonstrated a decreased motility of the luxS mutant strains. The metabolic 
and physiologic processes identified in this experiment are consistent with commonly 
encountered environmental changes associated with moving between vertebrate hosts and 
free living bacterial environments and provide important clues for better understanding 
the molecular processes responsible for the virulence differences observed in the previous 
chapter. 
 Collectively, the findings provide new insights into several levels of C. jejuni luxS 
based metabolism and quorum sensing, from the enzymology to its role in virulence.   
The results along each step of the process complement the findings of the previous work 
and provide a strong foundation for future research focusing on the interaction between 
LuxS/AI-2 and the adaptive response systems in Campylobacter pathobiology.  
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